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ABSTRACT OF DISSERTATION

TRAUMATIC BRAIN INJURY: CYCLOPHILIN D AS A THERAPEUTIC TARGET
AND THE NEUROPATHOLOGY CAUSED BY BLAST
With an estimated incidence of 1.5 million each year, traumatic brain injury (TBI)
is a major cause of mortality and morbidity in the United States. Opening of the
mitochondrial permeability transition pore (mPTP) is a key event contributing to TBI
pathology. Cyclophilin D (CypD), a matrix peptidyl-prolyl cis-trans isomerase, is
believed to be the regulating component of the mPTP. Cyclosporin A, an
immunosuppressant drug, inhibits CypD and blocks mPTP formation and has been shown
to be neuroprotective following TBI. However, it is unclear if CsA’s neuroprotective
mechanism is due to inhibition of CypD and/or immuno-suppression. Therefore to
directly assess the contribution of CypD to TBI pathology, CypD knockout mice were
subjected to a controlled cortical impact model of TBI. CypD ablation resulted in
increased tissue sparing, hippocampal protection, and improved mitochondrial complex I
driven respiration. Next a dose-response study of the Cyclophilin D inhibitor, NIM811,
was performed. NIM811 administration following TBI resulted in improved cognition,
increased tissue sparing, and improved mitochondrial function. These results suggest a
major role for CypD in TBI pathology and validate CypD as a potential therapeutic target
for TBI.
TBI has been proposed to be the signature injury of the current Middle Eastern
conflicts with an estimated prevalence of 15-60 % among combat soldiers. Although the
brain does appear to be vulnerable to blast, the exact mechanisms underlying the injury
remain unclear. Adult male Sprague-Dawley rats were exposed to a moderate level of
blast overpressure. Following blast, blood brain barrier disruption was evident at 3 and 24
h post-exposure, oxidative damage increased at 3 h post-exposure, and microglia were
activated in the hippocampus at 5 and 10 days post-exposure. This may widen future
neuroprotective avenues for blast since blast brain injury appears to share similar
mechanisms of injury with other TBI models.
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1. CHAPTER 1
Introduction and Background
1.1 An overview of traumatic brain injury
1.1.1 Traumatic brain injury in the US
In the United States, approximately 1.5 million individuals each year sustain a
traumatic brain injury (TBI) severe enough to warrant medical attention (Corrigan et al.
2010). This estimate is conservative since many individuals with mild TBIs do not seek
medical attention. Following hospitalization with TBI, as many as 3.2 million Americans
are currently living with an injury-related disability (Corrigan et al. 2010). The high
incidence and devastating consequences of TBI produce an enormous economic burden
in the US with total costs in excess of $60 billion a year. Unfortunately there are
currently no approved pharmacological treatments for TBI and care remains aimed at
acute clinical management and chronic rehabilitation therapy (Hatton 2001).
Major risk factors for civilian TBI (cTBI) are age and gender (Corrigan et al.
2010). The incidence of cTBI is increased in the elderly and the young, with 659 and 900
per 100,000, respectively. Increased risk-taking behavior in males contributes to them
being twice as likely as females to sustain a cTBI. Falls, motor vehicle accidents,
incidents involving the head being struck by or against an object, and assaults are the
major causes of cTBI (Fig. 1.1) (Langlois et al. 2006). Another major cause of cTBI are
the approximately 300,000 sports-related TBIs reported yearly (Thurman et al. 1998).
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Causes of Civilian Traumatic Brain Injury

Figure 1.1. Causes of civilian TBI (cTBI) in the United States. Falls, at 28 %, are the
most common cause of cTBI. The second most common cause of cTBI is motor vehicle
accidents (20 %). Followed by other (i.e. suicide attempt, unknown, bicycle crashes) at
22 %, struck by or against at 19 %, and violence at 11 %. (Modified from Langlois et al.
2006)
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TBI is a clinically heterogeneous neurological disorder which, depending on
injury severity, may produce symptoms ranging from a brief disruption in mental status
to long-lasting physical and mental disability. The Glasgow Coma Scale (GCS) is the
most widely used diagnostic tool for initial assessment of the severity of TBI (Andriessen
et al. 2010). The GCS is scored based on an individual’s eye response, verbal response,
and motor response. A GCS score of 13-15 represents a mild TBI, 9-12 moderate TBI,
and a ≤8 as a severe TBI.
1.1.2 Military TBI
Recent military operations in the Middle East have resulted in an increased public
awareness of TBI. However, military TBI isn’t a new phenomena and reports of “shell
shock” date back to World Wars I and II (WWI and WWII) (Jones et al. 2007). During
WWI soldiers without head wounds presented with amnesia, headache, and poor
concentration (Jones et al. 2007). Some of these soldiers had been in close proximity to a
blast event, while others with similar symptoms had not been anywhere near an
explosion. This observation lead a British psychologist to postulate that since soldiers are
exposed to large amounts of stress while in combat, that some cases of shell shock are
psychological in origin rather than the result of a brain lesion (Jones et al. 2007). Whether
or not the neuropathological symptoms following blast exposure are the result of head
trauma or psychological in origin continues to be debated.
Better battlefield technology (i.e. personal body armor) and medical care allow
present day soldiers to survive blasts that would have been deadly in other wars. As such
TBI has been proposed to be the signature injury of Operation Iraqi Freedom (OIF) and
3

Operation Enduring Freedom (OEF) (Elder and Cristian 2009). One recent study reported
that approximately 15% of 2525 Army infantry soldiers surveyed had experienced either
injuries with a loss of consciousness or injuries with altered mental status while serving
in Iraq, injuries which are indicative of mild traumatic brain injury (Hoge et al. 2008).
However some symptoms associated with postconcussive syndrome, such as headaches,
difficulty with concentration, and memory loss, overlap with post traumatic stress
disorder further complicating diagnosis of mild TBI in troops (Bryant 2001) (Table 1.1).
Many of these troops presenting with postconcussive symptoms experienced no overt
head trauma but share a common link, blast exposure.
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Table 1.1. Symptoms of posttraumatic stress disorder and traumatic brain injury.
N/A=not applicable (modified from Bryant 2001)
Symptom

PTSD

TBI

Depersonalization

Present

Present

Amnesia

Present

Present

Social Detachment

Present

Present

Nightmares

Present

N/A

Insomnia

Present

Present

Irritability

Present

Present

Concentration Deficits

Present

Present

Hypervigilence

Present

N/A
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1.1.3 TBI pathology and the secondary injury cascade
TBIs result from a mechanical input that directly damages tissue (primary
response) which initiates a complex secondary injury cascade (secondary response)
(LaPlaca et al. 2007). The primary response involves blood vessel damage, axonal
shearing, and cellular damage (Gaetz 2004; Smith et al. 2003). Vascular changes are a
key event and may result in decreased cerebral blood flow leading to ischemic tissue and
subsequent neuronal death (Nolan 2005). Brain edema is hypothesized to be the primary
contributor to the high mortality and morbidity associated with TBI (Donkin and Vink
2010). Edema can be classified as cytotoxic or vasogenic depending on the source of the
water. Cytotoxic edema represents an increase in intracellular water content with a
corresponding decrease in extracellular water. Vasogenic edema is the result of
movement of water from the vasculature into the extracellular space which may occur as
a result of blood brain barrier (BBB) breakdown following trauma. Vasogenic, but not
Cytotoxic, edema results in an increase in intracranial pressure.
Following TBI, there is progressive neurodegeneration that peaks between 48-72
h post-injury (Hall et al. 2005). Associated with this secondary injury is a several fold
increase in extracellular glutamate (Faden et al. 1989; Matsushita et al. 2000; Yi and
Hazell 2006) (Fig. 1.2). Increased glutamate results in the activation of α-amino-3hydroxy-5-methyl-4-isoxazoleproprionic

acid

(AMPA)

receptors,

which

cause

depolarization (Rho et al. 2010). This increase in glutamate can also lead to the activation
of voltage dependent Na+ channels, leading to further depolarization resulting from
increased Na+ entry into the cell and osmotic swelling of the neuron as Cl– passively
6

enters the cell, causing an influx of water. Aberrant depolarization can also result in the
removal of the Mg2+ block from N-methyl-daspartate (NMDA) receptors, allowing them
to be activated by glutamate. Activation of NMDA receptors and group I metabotropic
glutamate receptors allows Ca2+ influx into the neuron, subsequently activating
downstream mediators of programmed cell death (Sullivan et al. 2005; Walker 2007).
This disruption of Ca2+ homeostasis is believed to underlie glutamate-mediated toxicity
(excitotoxicity). The increase in intracellular calcium may cause sustained depolarization,
ionic imbalance, increased intracranial pressure (ICP), cerebral edema, calpain activation,
decreased ATP production, and increased reactive oxygen species (ROS) (Sullivan, 2005;
Yi and Hazell, 2006). In order to maintain neuronal Ca2+ homeostasis during periods of
excitotoxicity mitochondria serve as high-capacity Ca2+sinks. The role mitochondria play
in TBI neuropathology will be discussed in detail in a later section.
In addition to excitotoxicity, oxidative damage and inflammation are important
components of the secondary injury cascade. The brain is especially vulnerable to
oxidative damage as it accounts for approximately 20 % of basal O2 consumption, is rich
in peroxidizable membranous polyunsaturated fatty acids, and contains large amounts of
iron (Halliwell and Gutteridge 2007; Patel 2002; Rho 2004). Oxidative damage has been
shown to occur early (30 min-6 h) and spatially overlaps but temporally precedes peak
neurodegeneration (48 h); indicating a role for oxidative damage in secondary injury
(Deng et al. 2007). Post-TBI there are numerous sources of superoxide which include:
microglia, macrophages, arachidonic acid cascade (i.e. 5-lipoxygenase activity),
mitochondria, and dopamine oxidation (Lim and Lajtha 2006). Through a series of
reactions superoxide can form either the hydroxyl radical, nitrogen dioxide, or carbonate
7

radical which can initiate lipid peroxidation or protein carbonylation. Additionally, the
formation of 3-nitrotyrosine, by nitrogen dioxide, can alter protein structure and function
and therefore contributes to post-trauma pathology (Reed et al. 2009). Taken together, it
is evident that protein nitration and lipid peroxidation are early hallmarks of CNS injury
(Hall and Braughler 1993). Other evidence that implicates oxidative damage in TBI
neuropathology is the observation that antioxidant therapy is neuroprotective and
improves behavioral outcome (Hall et al. 2010; Mustafa et al. 2010; Singleton et al.
2010).
Immune activation is common among neurodegenerative diseases such as
Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis, and TBI (Amor et al.
2010). The notion that the CNS is “immune privileged” has been challenged recently and
evidence exists that demonstrates that the CNS is not isolated from the immune system
following TBI (Morganti-Kossmann et al. 2007). Circulating leukocytes have been
shown to transmigrate into the CNS following vascular disruption and activate resident
immune cells (microglia and astrocytes) (Hickey et al. 1991). Activation of microglia
occurs rapidly (6-48 h) following diffuse TBI and is followed by persistent activation (728 days) with phagocytic activity (Kelley et al. 2007). Activated microglia secrete proinflammatory cytokines and cytotoxic factors which exacerbate the immune response and
promote cell death (Morganti-Kossmann et al. 2002). Tumor necrosis factor (TNF) is
rapidly released after injury and acts initially as a pro-inflammatory cytokine (MorgantiKossmann et al. 2002). Interestingly the production of TNF stimulates production of
interleukin-6, an anti-inflammatory cytokine, which in-turn inhibits TNF synthesis.
Immunosuppresion using various immunosuppressants including cyclosporin A, FK506,
8

rapamycin, and methylprednisolone following neurotrauma has been shown to be
neuroprotective (Hailer 2008). Therefore, inflammation represents one component of the
secondary injury cascade that may be amenable to therapeutic intervention.

9

Figure 1.2. The excitotoxic cascade following injury. Injury results in increased levels of
extracellular glutamate causing influxes of Ca2+ into the dendrite via NMDA receptor
activation. If unchecked, this Ca2+ influx into neurons can result in a subsequent loss of
neuronal Ca2+ homeostasis. This disruption of Ca2+ homeostasis is believed to be a
defining factor of glutamate-mediated toxicity. Excessive mitochondrial Ca2+ results in
mitochondrial dysfunction.
10

1.2 Mitochondria and TBI
Approximately 800 million years ago a symbiotic relationship between two cells
led to the uptake of one cell by the other and made the development of multicellular
organisms possible (Scheffler 2008). Chondros (Greek), Korn (German) or grain
(English) were early (mid-1800s) descriptions of the morphology of distinct intracellular
structures that later (1898) became known as mitochondria. In the early 1900s Kingsbury,
Lehninger, and Warburg hypothesized that mitochondria were associated with cellular
respiration. Later, Mitochondria would become known as the reliable “powerhouse of the
cell” (Nicholls and Ferguson 2002). Now it appears that mitochondria not only produce
cellular energy but are also involved in the life and death of the cell. Recently
mitochondrial dysfunction has been implicated in a host of neurodegenerative disorders,
such as stroke, spinal cord injury, TBI, and Alzheimer’s disease (Sullivan et al. 2005).
1.2.1 Mitochondrial function
Mitochondria have an inner and outer membrane, each with its own specific
functions. The outer mitochondrial membrane contains porins which are non-specific
pores for molecules less than 10 kDa. The inner membrane is energy transducing and
contains components of the electron transport chain (ETC) along with specific carrier
proteins. Additionally the inner membrane exhibits folds, known as cristae, which act as
independent compartments (Zick et al. 2009). The space between the membranes is
referred to as the inter-membrane space and the internal compartment is known as the
matrix. The matrix contains enzymes related to the citric acid cycle. The citric acid cycle
reduces NAD+ to NADH. Electrons are then passed from NADH to the ETC.
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Mitochondria sustain the activity of neurons by producing ATP via the ETC (Fig.
1.3). The ETC is a series of redox reactions involving the transfer of electrons from one
carrier to the next (Alberts 2002). Electrons are transferred from carriers with low redox
potentials to carriers with high redox potentials. ETC chain carriers include cytochromes,
iron-sulfur proteins, and coenzyme Q. Complex I (NADH dehydrogenase) catalyzes the
transfer of two electrons from NADH to coenzyme Q (Nicholls 2002). Complex III
(ubiquinol-cytochrome c oxioreductase) catalyzes the transfer of electrons from
coenzyme Q to cytochrome c. Complex IV (cytochrome c oxidase) reduces one molecule
of oxygen to two molecules of water. As electrons are transported through Complexes I,
III, and IV protons are pumped into the inner membrane space, generating an
electrochemical gradient. This store of energy is used to generate ATP via the ATP
synthase.
Superoxide production is a byproduct of electron transport and occurs when
electrons escape or slip from the complexes and reduce O2 due to a backup of electrons in
the ETS. ROS production is linked to Δψ such that a high Δψ promotes increased ROS
production (Sullivan and Brown 2005). High Δψ results in altered redox potential of ETC
carriers and an increase in the half-life time of ubisemiquinone leading to increased ROS
production. Also, any damage to components of the ETC could lead to a stalling of
reduced intermediates of the ETC which would increase the probability of an electron
slipping and reducing O2 to form ROS.
In addition to producing the majority of ATP for the cell mitochondria also
regulate intracellular calcium levels. Mitchondrial Ca2+ accumulation is dependent upon a
12

Figure 1.3. The mitochondrial electron transport chain (ETS). As electrons are
transported down the ETS, complexes I, III, and IV translocate protons from the matrix,
generating an electrochemical gradient. This store of energy can then be coupled to ATP
production as protons move down the gradient and back into the matrix via F0F1 ATP
synthase. Superoxide production is a byproduct of electron transport.
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Ca2+ uniporter, Na+/Ca2+ antiporter, and H+/Na+ antiporter (Gunter and Gunter 1994;
Scheffler 2008). The Ca2+ uniporter transports Ca2+ into the matrix in response to Δψ.
Ca2+ efflux is driven by Na+/Ca2+ exchange which is driven by H+/Na+ exchange. Matrix
Ca2+ is buffered by forming a complex with phosphate (calcium-phosphate gel) (Nicholls
and Ferguson 2002). Physiologically, mitochondrial Ca2+ acts as an activator of several
key enzymes involved in oxidative phosporylation (i.e. pyruvate dehyrdrogenase)
(Gunter and Gunter 2001; Scheffler 2008). In response to rises in intracellular Ca2+ levels
mitochondria can act as a temporary sink for Ca2+ and maintain cytoplasmic Ca2+
homeostasis. However, excessive mitochondrial Ca2+ loading (i.e. during periods of
excitotoxicity) results in cell death initiation and will be discussed in detail in subsequent
sections.
1.2.2 Mitochondrial permeability transition
Excessive mitochondrial Ca2+ cycling/loading can result in mitochondrial
permeability transition (mPT) (Crompton and Costi 1990; Haworth and Hunter 1979).
mPT is the sudden increase in the inner membrane permeability to solutes of molecular
mass less than 1500 Da and was originally described by Hunter and Haworth in the 1970s
(Haworth and Hunter 1979; Hunter and Haworth 1979a; Hunter and Haworth 1979b;
Zoratti and Szabo 1995). mPT results in a loss of Δψ which uncouples electron transport
from the production of ATP (Halestrap 2009). Also mPT results in further mitochondrial
swelling, rupture of the outer mitochondrial membrane, and increased ROS production
(Mazzeo et al. 2009; Sullivan et al. 2005). mPT is thought to be mediated by opening of a
mega channel known as the mitochondrial permeability transition pore (mPTP) (Sullivan
14

et al. 2005). Although the exact composition of the mPTP remains to be elucidated, the
three most characterized components include the adenine nucleotide translocase (ANT),
cyclophilin D (CypD), and the volatage dependent anion channel (VDAC) (Fig. 1.4).
CypD is an 18 kDa matrix peptidyl-prolyl cis-trans isomerase (PPIase) encoded
by the nuclear gene PPIF that binds to the matrix face of ANT (Halestrap 2009;
Halestrap and Brenner 2003). PPIase activity is associated with an ability to catalyze the
isomerization of protein proline residues, which has dramatic effects on protein structure
and function. This Binding of CypD, in the presence of high levels of Ca2+, results in a
conformational change in ANT that converts ANT into a non-specific pore located in the
inner membrane (Griffiths and Halestrap 1991; Halestrap and Brenner 2003). The
interaction of the CypD/ANT complex with VDAC results in the formation of the mPTP.
In addition to Ca2+ induced mPTP, oxidative stress has been shown to promote mPTP by
enhancing the binding of CypD to ANT (Halestrap et al. 1997). This interaction between
ANT and CypD is blocked by cyclosporin A (CsA) (Crompton et al. 1988). Recent
studies in CypD knockout mice have demonstrated that mitochondria lacking CypD are
resistant to Ca2+ and ROS induced mPTP; further validating CypD involvement in mPTP.
Additionally, CypD knockout does protect against cardiac ischemia-reperfusion injury
(Nakagawa et al. 2005). However, CypD knockout did not protect against cell death
induced by pro-apoptotic Bcl-2 family members (Baines et al. 2005). This indicates that
cell death mediated by mPT may occur through two mechanisms; either CypD-dependent
mechanism or CypD-independent mechanism (Fig. 1.5).

15

Figure 1.4. Mitochondrial permeability transition pore. The mPTP is a conductance pore
that spans the inner and outer mitochondrial membranes and is putatively composed of
the adenine nucleotide translocase (ANT) of the inner membrane, matrix cyclophilin D
(CypD), and the voltage-dependent anion channel (VDAC) of the outer membrane.
(Right) Under normal conditions bound adenine nucleotides inhibit the opening of the
mPTP. (Left) Under pathophysiological conditions oxidative stress results in a
conformational change in ANT that prevents the binding of adenine nucleotides. In the
presence of high Ca2+ CypD binds to ANT and promotes formation of the mPTP.
Opening of the mPTP results in the release of apoptotic proteins (i.e. cytochrome C
(CytC) and apoptosis inducing factor (AIF).

16

Figure 1.5. The role of CypD in cell death. Ca2+ and ROS have been shown to promote
mPT and cell death through a CypD-dependent mechanism. Pro-apoptotic Bcl-2 family
members (i.e. Bax and Bak) induce mPT and cell death in a CypD-independent
mechanism. Likely, both pathways coexist.
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Following mPTP, pro-apoptotic proteins such as Smac/DIABLO, apoptosis inducing
factor (AIF), and cytochrome c can be released from the mitochondria, leading to
apoptosis (Fig. 1.6). Once released, cytochrome c forms a ATP-dependent complex with
apoptosis-inducing factor (Apaf-1) that in turn will activate caspase-9 and caspase-3 and
results in caspase-dependent cell death (Stoica and Faden 2010). In contrast, following
release AIF translocates to the nucleus where it causes DNA fragmentation in a caspaseindependent mechanism. The latter cell death pathway does not require ATP and can
proceed under conditions of bioenergetic compromise, such as in TBI.
1.2.3 Mitochondrial dysfunction following TBI
It is well established that mitochondrial dysfunction occurs early after TBI
(Robertson et al. 2007; Singh et al. 2006; Xiong et al. 1997). Associated with this early
mitochondrial dysfunction is an increase in ROS production, protein nitration, and lipid
peroxidation (Azbill et al. 1997; Braughler and Hall 1992; Hall et al. 1992). Specifically
oxidative damage to cortical and hippocamapal mitochondria has been shown to occur as
early as 30 min following TBI (Singh et al. 2006). Administration of antioxidants
following TBI has been demonstrated to improve mitochondrial function (Mustafa et al.
2010; Xiong et al. 1999; Xiong et al. 2005).

As a consequence of increased

mitochondrial Ca2+ and oxidative damage mitochondrial bioenergetics are compromised
following TBI (Sullivan et al. 2005). Additionally, mitochondrial calcium sensitivity has
been shown to decrease following TBI (Lifshitz et al. 2003). Also cytochrome c release is
well documented in TBI (Robertson et al. 2007; Sullivan et al. 2002).
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Figure 1.6. Highly simplified schematic diagram illustrating the pivotal role of
mitochondria in apoptotic and necrotic neuronal cell death following excitotoxic insult.
The excitatory amino acid glutamate increases Ca2+ influx into neurons. Mitochondria
sequester the Ca2+ in an effort to maintain cytosolic Ca2+ homeostasis. Excessive
mitochondrial Ca2+ cycling/loading can result in mitochondrial permeability that can be
mediated by the mitochondrial permeability transition pore (mPTP) opening or via
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increased permeability of the outer membrane without mPTP opening. In either case, proapoptotic proteins such as Smac/DIABLO, apoptosisinducing factor (AIF), and
cytochrome c (Cyto C) can be released from the mitochondria, leading to activation of
downstream caspases and apoptosis. Ca2+-induced mPT results in increased conductance
of the inner membrane, mitochondrial swelling, loss of ATP production due to decreased
membrane potential (Δψ), and increased reactive oxygen species (ROS) production.
These events promote mPT and can lead to necrosis depending on the extent and severity
of the insult or injury.

There is a wealth of evidence that demonstrates that mPTP inhibition following
TBI is neuroprotective. Administration of CsA following TBI has proven to be
efficacious in multiple models of TBI (Albensi et al. 2000; Alessandri et al. 2002; Buki et
al. 1999; Kilbaugh et al. 2011; Okonkwo et al. 1999; Okonkwo and Povlishock 1999;
Scheff and Sullivan 1999; Sullivan et al. 2000b; Sullivan et al. 2000c; Sullivan et al.
1999) as well as in other CNS injury models (Friberg et al. 1998; Yoshimoto and Siesjo
1999). Recently the non-immunosuppressive CsA analog, NIM811, was shown to
improve motor function, improve mitochondrial function, decrease oxidative damage,
and decrease neurodegeneration following TBI (Mbye et al. 2009; Mbye et al. 2008).

1.3 Blast physics and injury pathology
The Friedlander wave form mathematically describes the blast overpressure
(BOP) event generated by an explosion which includes a shock wave that is generated by
an instantaneous rise in atmospheric pressure (high-pressure shock wave) that decays
exponentially from the origin of the blast (Elsayed 1997) (Fig. 1.7). Following the initial
shock wave the pressure may drop below ambient pressure before returning to baseline.
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Figure 1.7. Friedlander wave. Open-field waveform characterized by an instantaneous
rise in ambient pressure (positive phase), followed by exponential decay that may drop
below ambient pressure (negative phase).
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It is important to note that this wave form only applies to blasts that occur in open air
environments while blasts that occur in enclosed environments display more complex
wave forms (Mayorga 1997). The duration of overpressure, the time between the initial
increases in pressure until its return to baseline, has been shown to have a direct impact
on injury severity (Elsayed 1997). Primary blast injuries are caused by the direct effects
of either overpressurization or underpressurization (barotrauma) (DePalma et al. 2005).
Air-filled organs and air-fluid interfaces are the most common sites of primary blast
injury, this is due to dynamic pressure differences at tissue density (air-fluid) interfaces
caused by the interaction of a high frequency stress wave and lower frequency shear
wave (Finkel 2006). Pulmonary barotrauma is one of the most common and life
threatening primary blast injuries and often results in pulmonary edema (Finkel 2006). As
a consequence of lung injury hypotension and hypoxemic secondary events are likely
contributors to overall outcome following blast (Dewitt and Prough 2008). Secondary
blast injuries are caused by objects set in motion by the shock wave that come in contact
with people. Tertiary blast injuries result from individuals being propelled away from the
site of the blast; these injuries are caused by individuals coming in contact with objects.
Quaternary blast injuries are considered injuries not associated with primary, secondary,
or tertiary injuries; such as burns, radiation exposure, and toxic inhalation (DePalma et al.
2005). Secondary and tertiary injuries are not specific to air filled organs and are capable
of producing brain injury, however little is known about the possibility of primary brain
blast injuries.
BOP is commonly modeled using blast tubes or shock tubes and less often in an
open-field environment (Cernak and Noble-Haeusslein 2010). In both tubes the animal is
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positioned in a holder that prevents secondary and tertiary blast injuries. Blast tube
shockwaves are generated by an explosion (i.e. combustion of a flammable gas or
detonation of an explosive charge). Whereas shockwaves generated in a shock tube are
produced by compressed air or gas. A shock tube is composed of a compression chamber
separated from an expansion chamber by a rupturable membrane (i.e. mylar membrane).
The compression chamber is loaded with air or gas until the failure point of the
membrane is reached, at which time the membrane ruptures and releases the gas/air into
the expansion chamber. The thickness of the membrane determines the peak overpressure
such that the thicker the membrane the higher the peak overpressure (Elsayed 1997). The
rapidly expanding gas/air results in a shockwave.
High levels of BOP, even without skull fracture, are capable of producing cerebral
contusion and subdural hemorrhage (Mayorga 1997). Recently pressure waves with
intensities capable of damaging nervous tissue were detected in the brains of rats exposed
to low level (40 kPa) BOP (Chavko et al. 2006). Although animal studies evaluating the
effect of BOP on the CNS are limited, some have shown the susceptibility of the CNS to
primary blast forces. One group studied the effect of BOP on the CNS with rats exposed
to a severe level of BOP; they reported cognitive deficits, neuronal swellings, glial
reaction, and oxidative stress (Cernak et al. 2001a; Cernak et al. 2001b). Another group
showed that electroencephalogram activity was depressed in pigs exposed to a mild BOP
event (Axelsson et al. 2000). More recent experimental reports in rats and pigs have
further characterized the neuropathology that ensues following BOP exposure. In order to
delineate the systemic effects versus the direct effects of BOP on brain injury, Long and
colleagues recently equipped rats with Kevlar vests in order to protect the abdomen and
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thorax from BOP. This study found that rats equipped with vests had less fiber
degeneration than those without vests. Also this study reported that rats exposed to 126
kPa BOP showed less neuropathology than those exposed to 147 kPa, indicating a dose
response between level of blast and neuropathology (Long et al., 2009). A recent swine
model of BOP indicated that pigs exposed to BOP exhibited cortical fiber degeneration
and

astrocytic

activation

(Bauman

et

al.,

2009).

Behavioral

changes

and

neuropathological signs of brain injury as a result of exposure to low levels of BOP have
also been reported (Saljo et al. 2008; Saljo et al. 2009c).

1.4 Specific Aims and Hypotheses
Inhibition of CypD with CsA and NIM811 following TBI has been shown to be
neuroprotective. However, both NIM811 and CsA have inverted U dose responses
following TBI. It remains to be determined whether the observed dose responses are due
to the interaction with CypD and/or other off-target interactions. Therefore CypD null
mice will be used to determine the contribution of CypD to secondary injury and to
provide further validation of CypD’s potential as a therapeutic target following TBI (Fig.
1.8). We hypothesize that genetic knockout of CypD will attenuate formation of the
mPTP, which will translate into increased cortical tissue sparing, increase hippocampal
neuron survival, and improved mitochondrial bioenergetics.
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Fig. 1.8. Model of the hypothesis that CypD is an essential mediator of cell death
following TBI. CypD knockout studies have demonstrated that, depending on the cell
death signal, mPT mediated cell death may proceed through either a CypD-dependent
mechanism or a CypD-independent mechanism. TBI is proposed to engage both
mechanisms. Therefore, pharmacological inhibition and genetic knockout of CypD is
hypothesized to provide neuroprotection following TBI.
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Because there may be a prerequisite for CypD for normal physiological
functioning, genetic ablation of CypD could prove detrimental. As such partial
pharmacological inhibition of CypD, rather than total inhibition, could prove to be a
better therapeutic strategy. The utility of CsA is limited due to its interaction with
calcineurin and resultant toxicity. Since NIM811 is less toxic than CsA and can be
administered in vivo at higher levels it may have greater therapeutic potential. NIM811
has been shown to attenuate mitochondrial dysfunction, decrease neurodegeneration, and
improve motor function following TBI, thus we hypothesize that administration of
NIM811 will improve cognition, increase tissue sparing, and improve mitochondrial
function.
Clinical and experimental data have shown that blast exposure does result in
neuropathology. In order to begin to understand the mechanism (s) of injury following
blast traumatic brain injury (bTBI) and to develop treatment strategies for bTBI it is
important to develop clinically relevant bTBI models. Therefore, we aim to characterize
the time-course of “classical” TBI markers of pathology following bTBI with the
eventual goal of selecting therapeutic targets for bTBI.
In order to test these hypotheses we have formulated the following specific aims:
Specific aim 1 will evaluate the hypothesis that genetic ablation of CypD will improve
behavioral function and provide neuroprotection following TBI. The effects of CypD
knockout on neuroprotection following TBI will be assessed using cortical tissue sparing
analysis and stereological assessment of hippocampal cell counts. Additonally, the effects
of CypD knockout on mitochondrial function following TBI will be determined.
26

Specific aim 2 will examine the hypothesis that pharmacological inhibition of CypD with
NIM811 will reduce tissue damage, attenuate mitochondrial dysfunction, and improve
functional outcome following TBI. MWM will be used to determine the effect of NIM811
on cognitive function following TBI. Following TBI, isolated mitochondria from
NIM811 and vehicle administered rats will be assayed to determine the effects of
treatment on mitochondrial function. Neuroprotective effects of NIM811 will be
determined using cortical tissue sparing analysis.
Specific aim 3 will test the hypothesis that BOP exposure will result in oxidative damage,
inflammation, and blood brain barrier (BBB) breakdown. Immunohistochemistry using
antibodies against 3-nitrotyrosine, 4-hydroxynonenal, IgG, and Cd11b/c will be used to
determine the profile of oxidative damage, inflammation, and blood brain barrier (BBB)
breakdown following TBI. Additionally, [3H]-PK11195 autoradiography will be used to
determine the extent of microglial activation following TBI.
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2. CHAPTER 2
Genetic Approach to Elucidate the Role of Cyclophilin D in TBI Pathology
2.1 Introduction
Cell death following TBI occurs in two waves; an immediate wave of cell death
as a consequence of physical injury and a secondary wave of cell death resulting from
biochemical and/or physiological signals (Stoica and Faden 2010). Excitotoxicity
following injury results in disrupted intracellular Ca2+ homeostasis. In an effort to
maintain cytosolic Ca2+ levels mitochondria buffer rises in intracellular Ca2+. However,
mitochondrial Ca2+ buffering is finite and excessive mitochondrial Ca2+ loading results in
mitochondrial dysfunction. As such mitochondrial dysfunction has been implicated as a
key pathological event following TBI. Mitochondria regulate both necrotic and apoptotic
cell death pathways likely via modulation of the mPTP (Green and Reed 1998; Schneider
2005) . Although the exact molecular identity of the mPTP is unknown the adenine
nucleotide translocase (ANT) of the inner membrane, the voltage-dependent anion
channel (VDAC) of the outer membrane, and the matrix-specific peptidyl-prolyl cis–
trans isomerase cyclophilin D (CypD) appear to be mPTP components. Cyp-D
translocates from the matrix to the mPTP where it interacts with ANT and promotes pore
formation (Lemasters, et al., 2009).
Recently, Ca2+ and ROS were shown to promote pore formation by a CypD
dependent mechanism (Baines et al. 2005; Basso et al. 2005). Also, CypD knockout
resulted in remarkable protection from cardiac ischemia-reperfusion injury (Nakagawa et
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al. 2005). However, not all cell death pathways initiated by the mitochondria are CypD
dependent (i.e. Bcl-2 family members induce apoptosis by a CypD independent
mechanism) (Green and Kroemer 2004). CypD knockout did not protect against cell
death mediated by Bcl-2 family members (Baines et al. 2005).
The connection between CypD and cell death following TBI has been supported
by studies demonstrating that inhibition of mPTP formation with NIM811 and CsA is
neuroprotective. Presumably, the neuroprotective actions of CsA and NIM811 are
attributable to their inhibition of CypD, which prevents the binding of CypD to ANT and
formation of the mPTP (Nicolli, et al., 1996). However, it is difficult to discern the
protective mechanisms of NIM811 and CsA given that both have targets other than
CypD. Since cell death may occur independent of CypD the overall role CypD plays in
cell death following TBI remains largely unknown.
To further elucidate the role CypD plays in neuropathology following TBI mice
lacking the CypD enconding gene Ppif were subjected to a controlled cortical impact
model of TBI. We hypothesized that genetic knockout of CypD would confer
neuroprotection following TBI. At 18 days post-injury cortical tissue sparing assessment
was performed. To determine the effects of

CypD knockout on hippocampal cell

survival, neurons were counted for regions dentate gyrus (DG), CA3, and CA1 using the
optical dissector method. Next we determined the effects of CypD knockout on
mitochondrial function following TBI. The data demonstrate that knockout of CypD,
likely via maintenance of mitochondrial homeostasis, spares cortical tissue and protects
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CA3 neurons following TBI and support the hypothesis that CypD is an important
mediator of cell death following TBI.
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2.2 Methods
2.2.1 Animals, injury, and experimental design
All experimental animal procedures were approved by the Animal Care and Use
Committee at the University of Kentucky. Adult wild-type (C57BL/6) and CypD
knockout mice were subjected to a severe (1.0 mm) unilateral controlled cortical
contusion TBI or sham-operation (n=18). Briefly, the skull was exposed through a
midline incision and an approximately 4 mm craniotomy was made lateral to the midline
and centered between bregma and lambda. A cortical contusion was produced using a
pneumatically driven injury device with a 3 mm tip as previously described (Mbye et al.
2008). Following injury a prosthetic skull cap was glued over the craniotomy site.
Animals remained on a 37⁰ heating pad until their righting reflex had returned.

2.2.2 Tissue processing and measurements of tissue sparing
At 18 days post-injury, wild-type and CypD knockout mice were anesthetized by
an overdose of pentobarbital and transcardially perfused with physiological saline
followed by 4% paraformaldehyde (n=4-5/group). After removal, the brains were placed
in 4% paraformaldehyde-sucrose (15%) for an additional 24 h. Coronal sections (30 μm)
were then cut using a freezing microtome, throughout the rostrocaudal extent of the brain,
extending through the septal area to the most posterior extent of the hippocampus.

2.2.3 Optical Fractionator Method
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All sampling was conducted using an Olympus BX51 microscope with a 60 X oil
objective, with an ASI automated stage (Eugene, OR). Bioquant Image analysis software
(R and M Biometrics, Memphis, TN) was used to estimate the total cell number in
ipsilateral hippocampal regions CA1, CA3, and DG using the optical fractionator method
as previously described (Baldwin et al. 1997). Briefly, this method involves sampling a
known fraction of the section thickness, under a known fraction of the sectional area, in a
known fraction of the sections that contain the structure. The total number of neurons (N)
is estimated by: N = ƩQ * t/h * 1/asf * 1/ssf, where ƩQ is the number of neurons counted
in the optical dissectors, t is the tissue thickness (30 µm), h is the height of the dissector
(25 µm), 1/asf is the counting grid area (100 X 100)/the dissector area (CA3, CA1-15 µm
X 15 µm; DG-10 µm X 10 µm), and 1/ssf is the sampling section fraction (12).

2.2.4Mitochondrial isolation and respiration analysis
At 6 h post-injury wild-type and CypD knockout mice were asphyxiated with CO2
until unconscious, decapitated, and the brains were rapidly removed and placed in
isolation buffer (215 mM mannitol, 75 mM sucrose, 0.1% BSA, 20 mM HEPES, and 1
mM EGTA; pH 7.2) (n=3/group). The cortices were dissected with a 3 mm-diameter
punch centered on the site of impact. The cortical tissue punch contained tissue from the
site of the impact and the surrounding penumbra. The tissue punches were homogenized
and isolated by differential centrifugation as previously described (Singh, et al., 2006).
Briefly, the homogenate was centrifuged twice at 1300 xg for 3 min. The pellet was
discarded, and the supernatant was further centrifuged at 13,000 xg for 10 min. In order
to release synaptic mitochondria, the crude mitochondrial pellet was subsequently
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subjected to nitrogen decompression using a nitrogen cell disruption bomb (1200 psi, 10
min). After nitrogen disruption, the mitochondria were suspended in 3.5 mL of 15%
percoll and placed on a percoll gradient consisting of 3.5 mL of 24% percoll and 3.5 mL
of 40% percoll in 13-mL ultraclear tubes. The gradient was centrifuged in a fixed-angle
rotor at 30,400 xg for 10 min at 4°C. The fraction accumulated at the interphase of the
40% and 24% percoll layers was carefully removed and diluted with isolation buffer
without EGTA, then centrifuged at 12,300 xg for 10 min at 4°C. The supernatants were
carefully removed, and the pellet was resuspended in isolation buffer without EGTA and
centrifuged at 13,000 xg for 10 min at 4°C. The mitochondrial pellets were recentrifuged
at 10,000 xg for 5 min at 4°C to yield tighter pellets. The final mitochondrial pellet was
resuspended in isolation buffer without EGTA to yield a concentration of ~10 mg/mL.
The protein concentration was determined using a bicinchoninic acid protein assay kit
(Pierce, Rockford, IL).
Mitochondrial respiration was measured using a Seahorse Biosciences XF24 Flux
Analyzer (North Billerica, MA) as previously described (Sauerbeck et al. 2011). Briefly,
pyruvate plus malate plus ADP, oligomycin, FCCP, and rotenone plus succinate were
injected sequentially through ports A–D, respectively, in the Seahorse Flux Pak
cartridges to yield final concentrations of 5 mM (pyruvate), 2.5 mM (malate), 1 mM
(ADP), 1 μg/ml (oligomycin), 1 μM (FCCP) and 100 nM (rotenone), 10 mM (succinate),
respectively.

2.2.5 Statistics
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For all statistical comparisons, significance was set at p < 0.05. Tissue sparing
assessment data were analyzed using unpaired t-test. Cell count data were analyzed using
a two-factor ANOVA followed by Bonferroni post-hoc analysis. Mitochondrial data were
analyzed using one-way ANOVA followed by SNK post-hoc analysis.
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2.3 Results
2.3.1 Cyclophilin D knockout increases tissue sparing following TBI
In order to determine the effects of CypD knockout on tissue sparing following TBI,
wild-type and CypD knockout mice were subjected to a severe (1.0 mm) CCI TBI. In
these experiments cortical tissue sparing was determined at 18 days post-injury utilizing
the Calvalieri method. CypD knockout mice demonstrated a significant increase in tissue
sparing (84.1 ± 2.1) compared to wild-type mice (76.2 ± 2.248) (p < 0.03) (Fig. 2.1).

35

Figure 2.1. CypD knockout increases tissue sparing following TBI. Quantitative
assessment of tissue sparing revealed that CypD knockout animals demonstrated a
significant increase in tissue sparing when compared to wild-type animals. Data points
represent group means ± SD. *p = 0.033.
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2.3.2 Cyclophilin D knockout protects CA3 hippocampal neurons
The number of surviving CA1, CA3 and DG neurons were estimated using the optical
fractionator method at 18 days post-injury (Fig. 2.2). In wild-type mice, injury
significantly decreased the number of neurons in ipsilateral CA1 [F(1,16) = 110.7; p <
0.001], CA3 [F(1,16) = 21.6; p < 0.001], and DG [F(1,16) = 120.1; p < 0.01]. In CypD
knockout mice, injury significantly decreased the number of neurons in ipsilateral CA1
[F(1,16) = 120.1; p < 0.001] and DG [F(1,16) = 120.1; p < 0.001]. In ipsilateral CA3 of
CypD knockout TBI mice, numbers of surviving neurons were not significantly different
than CypD knockout sham mice.
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Figure 2.2. CypD knockout protects CA3 hippocampal neurons following TBI. Injury
significantly decreased the number of neurons in CA1 (A), DG (B), and CA3 (C) in wildtype mice. CypD knockout protected CA3 neurons from injury-induced cell loss. Data
points represent group means ± SD. *p< 0.05.
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2.3.3 Cyclophilin D knockout improves mitochondrial complex I driven respiration
In order to determine the effects of CypD knockout on mitochondrial respiration
following TBI, mitochondria were isolated at 6 h post-injury from the ipsilateral cortex of
wild-type and CypD knockout mice. In the presence of pyruvate plus malate plus ADP,
injury-induced impairments in complex I driven respiration (State III respiration) were
attenuated by CypD knockout (p<0.05) (Fig. 2.3). Complex II driven respiration was
significantly reduced in both CypD knockout and wild-type mice (p<0.05).
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Figure 2.3. CypD knockout attenuates mitochondrial dysfunction following TBI. At 6 h
post-injury wild-type mice (white bars) complex I driven respiration was significantly
reduced compared to sham (black bars); CypD knockout attenuated this dysfunction.
Data points represent group means ± SD. #p< 0.05 v WT-sham, *p<0.05 v KO-injured.
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2.4 Discussion
We investigated the role of Cyp-D in TBI, in which Cyp-D dependent cell death
mechanisms have been implicated including Ca2+ dishomeostasis and increased ROS
production. The present data for the first time demonstrates that genetic ablation of CypD is neuroprotective following TBI. Importantly, Cyp-D knockout attenuated injuryinduced inhibition of mitochondrial complex I respiration. Therefore, the present results
confirm the key role Cyp-D plays in cell death following TBI.
Pharmacological studies have suggested an important role for Cyp-D in
neurodegeneration and TBI. Administration of CsA has been shown to be neuroprotective
following multiple experimental models of TBI (Buki et al. 1999; Kilbaugh et al. 2011;
Okonkwo et al. 1999; Scheff and Sullivan 1999; Sullivan et al. 2000c; Sullivan et al.
1999). Since CsA interacts with Cyp-D and inhibits calcineurin, the neuroprotective
mechanism(s) of CsA is greatly debated. NIM811, which inhibits Cyp-D but doesn’t
affect calcinuerin, has also been shown to have neuroprotective properties following TBI
and spinal cord injury. However, NIM811 has a U-dose response curve following TBI
which may indicate that NIM811 is acting through other potential off-target mechanisms.
Genetic knockout of Cyp-D provides a novel approach for directly examining the role
that Cyp-D plays without the confounding off-target effects of pharmacological studies.
The observed improvement in mitochondrial complex I activity following TBI in
Cyp-D knockout mice likely reflects a secondary effect of inhibition of mPTP formation
by loss of Cyp-D (Mbye et al. 2008). The attenuation of decreases in mitochondrial
complex I respiration rates suggest that loss of Cyp-D increases mitochondrial resistance
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to TBI. These findings are in line with studies involving mitochondria isolated from
CypD deficient mice which showed that mitochondria lacking CypD are resistant to Ca2+
induced mPTP formation (Baines et al. 2005).
Although it is generally accepted that the mPTP plays a role in cell death the
mechanisms underlying induction of mPTP following TBI remain unclear. There appears
to be two alternative routes to cell death, one that is Cyp-D dependent and an alternative
route that is Cyp-D independent; both pathways have been implicated in TBI. An
important question is if inhibition of one pathway is sufficient to overcome cell death or
if inhibition of one pathway could enhance/promote the other pathway, with the same
result either way-cell death.

There is growing evidence that suggests that Cyp-D

knockout is protective in neurodegenerative disorder models (Du et al. 2008; Du et al.
2011; Wang et al. 2009). Interestingly, one study found that the prevalent cell death
pathway after hypoxic-ischemic brain injury is developmentally regulated such that CypD dependent pathway is more critical in the development of brain injury in the adult
(Wang et al. 2009). This study demonstrated that Cyp-D knockout significantly reduced
hypoxic-ischemic brain injury in adult mice while knockout exacerbated the injury in
neonatal mice. Related to this, our results indicate that maintenance of mitochondrial
homeostasis, by the absence of Cyp-D, following TBI is protective.
We have previously demonstrated that continuous infusion of CsA for up to 7
days produces greater protection than a single dose administration of CsA following TBI
(Sullivan et al. 2000c). Also, we have recently shown that the earlier the treatment with
CsA is initiated following TBI the greater the neuroprotection that is afforded (Sullivan et
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al. 2011). Taken together these results suggest that the mechanisms underlying cell death
following TBI are active for a prolonged period of time and that early intervention
provides the greatest benefit. Consistent with these findings, genetic knockout of Cyp-D
indicated that following TBI complete absence of Cyp-D from the onset was indeed
beneficial.
Cyp-D knockout was recently shown to protect neurons against glutamate
triggered cell death in vitro (Li et al. 2009). Importantly, the protection was dependent on
the severity of the glutamate insult such that protection was not observed following the
more severe insult. This may indicate that following more severe insults that Cyp-D
independent cell death mechanisms are more prevalent. In unpublished data from our lab
we have shown that following a mild (0.5 mm) CCI TBI there is modest neuroprotection.
Our results suggest that Cyp-D dependent cell death mechanisms are more prevelant in
TBI, as Cyp-D ablation resulted in protection from mild and severe TBI.
This is the first study to report the effects of Cyp-D knockout in a model of
traumatic brain injury and we showed that the lack of Cyp-D significantly decreased the
damage associated with TBI. Thus, Cyp-D dependent cell death is critically involved in
TBI, supporting the hypothesis that Cyp-D is a valid target for neuroprotection following
TBI.
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3. CHAPTER 3
Post-injury administration of the mitochondrial permeability transition pore
inhibitor, NIM811, is neuroprotective and improves cognition following traumatic
brain injury in rats
(Accepted for publication in Journal of Neurotrauma)
3.1 Introduction
Traumatic brain injury (TBI) is characterized by significant neurological
dysfunction which results from a primary rapid necrosis of tissue at the site of injury
followed by a delayed secondary injury. Mechanisms believed to play a role in cell death
following TBI are numerous and include excitotoxicity, inflammation, mitochondrial
dysfunction, oxidative stress, calpain activation, and caspase activation (Deng-Bryant et
al. 2008; Deng et al. 2007; Hall et al. 2004; Kelley et al. 2007; Lifshitz et al. 2003;
Lifshitz et al. 2004; McGinn et al. 2009; Morganti-Kossmann et al. 2007; Saatman et al.
2010; Singh et al. 2006). Following TBI, excessive activation of N-methyl-D-aspartate
(NMDA) receptors by excitatory amino acids results in an elevation in cytoplasmic Ca2+
(Hinzman et al. 2010). Under normal conditions mitochondria primarily act to regulate
energy metabolism and as high-capacity Ca2+ sinks (Giacomello et al. 2007). However,
excessive mitochondrial Ca2+ loading following TBI may result in formation of the
mitochondrial permeability transition pore (mPTP) (Sullivan et al. 2005). A consequence
of mPTP formation is a loss of membrane potential, which supports the uncoupling of
electron transport from ATP production. The release of pro-apoptotic molecules (i.e.,
cytochrome C, Smac/Diablo, and apoptosis inducing factor) from the mitochondria is, in
part, orchestrated by mPTP and leads to the activation of cell death pathways (Jordan et
al. 2003). An additional consequence of mPTP formation is the production of reactive
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oxygen species (ROS) which contribute to cellular damage by oxidizing cellular proteins
and lipids (Mazzeo et al. 2009).
Well-known components of the mPTP include the adenine nucleotide translocase
(ANT) of the inner membrane, the voltage-dependent anion channel (VDAC or Porin) of
the outer membrane, and the matrix-specific peptidyl-prolyl cis–trans isomerase
cyclophilin D (Cyp-D). Cyp-D translocates from the matrix to the mPTP where it
interacts with ANT and promotes pore formation (Lemasters et al. 2009). Cyclosporin A
(CsA) and NIM811, inhibit the opening of mPTP by binding Cyp-D, which prevents the
binding of Cyp-D to ANT (Nicolli et al. 1996).
Abundant evidence demonstrates the neuroprotective efficacy of mitochondrial
permeability transition pore inhibition following TBI (Cook et al. 2009; Vink et al. 2001).
Administration of CsA following TBI significantly improves mitochondrial function and
subsequently decreases neuronal damage (Buki et al. 1999; Okonkwo and Povlishock
1999; Scheff and Sullivan 1999; Sullivan et al. 2000b; Sullivan et al. 2000c; Sullivan et
al. 1999). However, studies investigating the effects of CsA administration on cognition
following TBI are limited and contradictory. In one study CsA’s neuroprotection directly
translated into improved cognition (Alessandri et al. 2002). In contrast another study
reported that CsA administration did not result in improved cognition following
experimental TBI (Riess et al. 2001). Therefore the absence of cognitive data supporting
the use of CsA following TBI warrants further investigation of mPTP inhibitors.
The non-immunosuppressive cyclosporin A analog, N-methyl-4-isoleucinecyclosporin (NIM811), lacks the ability to inhibit calcineurin and therefore can be
administered in vivo at much higher doses than CsA (Rosenwirth et al. 1994; Waldmeier
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et al. 2002). NIM811 has been shown to have a favorable pharmacokinetic profile with
oral bioavailability similar to that of CsA (Rosenwirth et al. 1994). The toxicity of
NIM811 is significantly less than CsA as indicated by inducing fewer nephrotoxic
effects. Recently we demonstrated that a 10-mg/kg dose of NIM811 was as effective as a
20-mg/kg dose of CsA in attenuating mitochondrial dysfunction and neurodegeneration
and improving motor function following experimental controlled cortical impact (CCI)
TBI in mice (Mbye et al. 2009; Mbye et al. 2008).
In the present study, we used the CCI TBI model to assess whether or not the
effects of NIM811 administration to rats would duplicate the neuroprotective effects of
NIM811 previously observed with mice and to determine if these effects would translate
into improved cognition. Firstly, we determined the dose-response of NIM811 for
increased tissue sparing. Secondly, we determined the effect of the optimal dose of
NIM811 for improved cognitive performance using the Morris Water Maze (MWM).
Thirdly, we assessed the effect of the optimal dose of NIM811 for improving
mitochondrial function and decreasing mitochondrial oxidative damage. The results
demonstrate that NIM811 administration is capable of both conferring neuroprotection
and improving cognition following TBI.
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3.2 Methods
3.2.1 Animals, injury, and experimental design
All experimental animal procedures were approved by the Animal Care and Use
Committee at the University of Kentucky. Adult male Sprague-Dawley rats weighing
approximately 300-350 g were subjected to a severe (2.0 mm) unilateral controlled
cortical contusion TBI or sham-operation (n=66). Surgical procedures were performed as
previously described under 2% isoflurane (Davis et al. 2008). For tissue sparing
assessment studies, animals were administered vehicle (100 % DMSO) or NIM811 (Nmethyl-4 isoleucinecyclosporin; Novartis Pharma Ltd., Basal, Switzerland) (5, 10, 20, or
40 mg/kg) at 15 min and 24 h post-injury depending on group designation (n=5/group).
Animals for behavioral studies were administered vehicle or NIM811 (10 mg/kg) at 15
min and 24 h post-injury. Animals designated for mitochondrial studies were
administered either vehicle or NIM811 (10 mg/kg) at 15 min post-injury (n=5/group).

3.2.2 Tissue processing and measurements of lesion volume
At 15 days post-injury, animals were anesthetized by an overdose of pentobarbital
and transcardially perfused with physiological saline followed by 4% paraformaldehyde.
After removal, the brains were placed in 4% paraformaldehyde-sucrose (15%) for an
additional 24 h. Coronal sections (50 μm) were then cut using a freezing microtome,
throughout the rostrocaudal extent of the brain, extending through the septal area to the
most posterior extent of the hippocampus.
The extent of tissue sparing following TBI was assessed blindly with respect to
treatment group. The assessment employed an unbiased stereological protocol, the
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Cavalieri method (Michel and Cruz-Orive 1988). A systematic random subset of sections
from the region of interest (minimum of 12), separated by a known distance, is then
selected for analysis. Cortical tissue sparing was measured using Image J (NIH) software.
On each section, the total cortical area, defined as the dorsal aspect of lamina I to the
dorsal aspect of the corpus callosum, was determined for the entire ipsilateral
hemisphere. The cortical area of the contralateral hemisphere was also determined in an
identical fashion using the Cavalieri method. The volume of ipsilateral tissue spared was
compared with the volume of tissue spared contralateral to the injury, and the results
were expressed as the percentage tissue spared [(ipsilateral/contralateral) X 100].

3.3.3 Cognitive assessment
Two separate cohorts of animals were used for MWM testing. Cohort I involved
NIM811 treated and vehicle treated rats (n=5/group) and only involved training. Cohort
II included sham (n=5), NIM811 treated (n=8), and vehicle treated (n=8) rats and
involved training and a probe trial. For training data, cohorts I and II were averaged. For
probe data, only cohort II was used. Beginning 10 days after the injury, spatial memory
was assessed using an adapted MWM paradigm (Morris 1984) as previously described
(Guseva et al. 2008). The water maze was divided into four quadrants, with the platform
submerged in one of the quadrants. Visual cues located throughout the testing room aided
in spatial orientation. Swimming during the “transfer” trials was videotaped and
processed using a video motion analyzer (Columbus Instruments, Columbus, OH).
Briefly, for each trial quadrant, entry was randomized for different starting positions, and
animals were allowed to swim until they found the platform, where they remained for 15
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sec after the trial. If the platform was not located within the allotted 60-sec trial, the
animal was placed on the platform for 15 sec. Each day consisted of four acquisition
trials separated by 5-min intervals. Over 5 days a total of 20 acquisition trials were
administered for each animal. The average time to reach the platform each day was
calculated for individual groups. For cohort II, training was followed by one 15 sec probe
trial. The platform was removed from the pool for the probe trial. The number of times
each animal crossed the platform was recorded.

3.3.4 Mitochondrial isolation, mitochondrial calcium buffering capacity, and
measurement of mitochondrial function
All steps of the mitochondrial isolation protocol were performed on ice. At 6 h
post-injury rats were asphyxiated with CO2 until unconscious, decapitated, and the brains
were rapidly removed and placed in isolation buffer (215 mM mannitol, 75 mM sucrose,
0.1% BSA, 20 mM HEPES, and 1 mM EGTA; pH 7.2). The cortices were dissected with
a 5 mm-diameter punch centered on the site of impact. The cortical tissue punch
contained tissue from the site of the impact and the surrounding penumbra. The tissue
punches were homogenized and isolated by differential centrifugation as previously
described (Singh et al. 2006). Briefly, the homogenate was centrifuged twice at 1300 xg
for 3 min. The pellet was discarded, and the supernatant was further centrifuged at 13,000
xg for 10 min. In order to release synaptic mitochondria, the crude mitochondrial pellet
was subsequently subjected to nitrogen decompression using a nitrogen cell disruption
bomb (1200 psi, 10 min). After nitrogen disruption, the mitochondria were suspended in
3.5 mL of 15% percoll and placed on a percoll gradient consisting of 3.5 mL of 24%
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percoll and 3.5 mL of 40% percoll in 13-mL ultraclear tubes. The gradient was
centrifuged in a fixed-angle rotor at 30,400 xg for 10 min at 4°C. The fraction
accumulated at the interphase of the 40% and 24% percoll layers was carefully removed
and diluted with isolation buffer without EGTA, then centrifuged at 12,300 xg for 10 min
at 4°C. The supernatants were carefully removed, and the pellet was resuspended in
isolation buffer without EGTA and centrifuged at 13,000 xg for 10 min at 4°C. The
mitochondrial pellets were recentrifuged at 10,000 xg for 5 min at 4°C to yield tighter
pellets. The final mitochondrial pellet was resuspended in isolation buffer without EGTA
to yield a concentration of ~10 mg/mL. The protein concentration was determined using a
bicinchoninic acid protein assay kit (Pierce, Rockford, IL).
Mitochondria isolated from naïve animals were used to assess the effect of in
vitro NIM811 treatment (1 µM) on mitochondrial Ca2+ buffering capacity and mPTP.
Mitochondrial

Ca2+

buffering

capacity

was

assessed

using

a

fluoresecent

spectrofluorophotometer assay as previously described (Brown et al. 2006). 100 nM
CaG5N (excitation, 506 nm, emission, 532 nm) was used to measure extramitochondrial
Ca2+ in a Shimadzu RF-5301PC spectrofluorophotometer (Kyoto, Japan). Ca2+ was
infused using a KD Scientific model 310 series infusion syringe pump (Holliston, MA)
(160 nmol of Ca2+/mg of protein/min).
Mitochondrial respiration was assessed using a miniature Clark-type oxygen
electrode (Hansatech Instruments, Norfolk, UK) in a sealed, thermostatically controlled
chamber at 37⁰C as described previously (Patel et al. 2010; Sullivan et al. 2004).
Mitochondrial respiration was assessed using standard polarographic methods with
pyruvate and malate (5 and 2.5 mM, respectively) as oxidative substrates (Sullivan et al.
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2003). Following the addition of pyruvate and malate (state II respiration), 120 nmol
ADP was added to the chamber to induce state III respiration; this was followed by the
addition of 1 µm oligomycin to block ATP synthesis (state IV respiration). The
respiratory control ratio (RCR) was used as an overall metric of mitochondrial
functionality. The RCR was calculated by dividing the slope of the response of isolated
mitochondria to state III respiration by the slope of the response to state IV respiration.

3.3.5 Mitochondrial Oxidative Damage Assessment
Mitochondrial lipid peroxidation was assessed as previously described by
performing slot blots, using an antibody directed against 4-hydroxynonenonal (4-HNE)
(Sullivan et al. 2002; Sullivan et al. 2004). Mitochondrial protein oxidation was assessed
by measuring protein carbonyls using the OxyBlot Protein Oxidation Detection Kit
(OxyBlot; Intergen Company, Purchase, NY) as previously described (Pandya et al.
2007). The films were scanned and the densitometric measurements were quantified by
outlining the reactive bands to obtain average pixel intensities, using NIH Image
software.

3.3.6 Statistical Analysis
For all statistical comparisons, significance was set at p ≤ 0.05. Tissue sparing
assessment data were analyzed using a one-factor analysis of variance (ANOVA)
followed by post-hoc analysis (Fisher PLSD test). MWM training data were analyzed
using a two-factor repeated-measure ANOVA, with the day of training as the repeated
measure, followed by Bonferroni post-hoc analysis. MWM probe data was analyzed by
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one-factor ANOVA followed by SNK post-hoc analysis. Mitochondrial RCR and
oxidative damage data were analyzed using unpaired t-tests.

52

3.3. Results
3.3.1 Dose-response analysis of NIM811 on cortical tissue sparing following TBI
To establish a dose-response curve for NIM811, adult rats received a severe unilateral 2mm cortical contusion and were administered various doses (5, 10, 20, or 40 mg/kg) of
NIM811 or vehicle at 15 min post-injury with a subsequent injection 24 h later. In these
experiments, cortical tissue sparing was determined at 15 days post-injury utilizing the
Cavalieri method. An ANOVA revealed a significant group effect in the percentage of
the cortex damaged following TBI [F(4, 20) = 9.359; p < .0002] (Fig. 3.1). Post-hoc
comparisons indicated that all groups administered NIM811 demonstrated significantly
greater tissue sparing (p < 0.05) compared to vehicle-treated animals. However, animals
receiving a 10-mg/kg dose of NIM811 demonstrated a significant (p < 0.0001) increase in
tissue sparing compared to all other doses of NIM811.
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Figure 3.1. NIM811 administration increases tissue sparing following TBI. Tissue
sparing was differentially affected depending on the dose of NIM811 administered
following a severe (2 mm) CCI TBI. Adult rats were administered various dosages of
NIM811 (5, 10, 20, or 40 mg/kg) or vehicle at 15 min and 24 h post-injury, with
subsequent tissue sparing assessment at 15 days post-injury. (A) Representative sections
from a vehicle-treated animal and a 10-mg/kg NIM811-treated animal (B) Quantitative
assessment of tissue sparing revealed that all animals receiving NIM811 demonstrated a
significant increase in tissue sparing when compared to vehicle-treated animals. Data
points represent group means ± SEM. #p< 0.05 vs. vehicle; @p<0.0001 vs. all other
doses of NIM811.
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3.3.2 NIM811 improves behavioral outcome following TBI
Experimental CCI TBI produces significant deficits in both acquisition and
retention of the Morris water maze (MWM) spatial memory task (Scheff, et al., 1997).
Spatial memory was assessed beginning 10 days post-injury using the MWM. In this
experiment, the effect of the 10-mg/kg dose of NIM811 on MWM performance was
compared to vehicle. NIM811 administration was associated with significant
improvement in the acquisition phase of the MWM. ANOVA results revealed significant
effects of the day of testing [F(4, 28) = 23.95; p < 0.0001] , treatment [F(2, 28) = 4.766; p
= 0.0165] and a day X treatment interaction [F(8, 28) = 2.51; p=0.0152] (Fig. 3.2A). On
day 13, post-hoc analysis of daily latencies indicated that NIM811-treated animals had
significantly improved MWM performance compared to vehicle-treated animals (p<
0.01). Also, on day 14 vehicle treated rats demonstrated significantly increased escape
latency compared to sham animals (p < 0.01). During the probe trial, NIM811 treated rats
crossed the platform significantly more times than vehicle treated animals [F(2, 20) =
3.555; p = 0.050] (Fig. 3.2B). No significant group differences in swim speed were
present during the acquisition phase of testing (data not shown).
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Figure 3.2. NIM811 treatment improves MWM performance following TBI. (A) Animals
that received 10 mg/kg of NIM811 (15 min and 24 h post-injury) (triangles) found the
submerged platform significantly faster on day 13 than vehicle-treated animals (squares).
(B) Number of platform crossings over the 15 sec memory retention test. Vehicle treated
animals significantly found the platform fewer times than sham animals; NIM811
treatment attenuated this deficit in memory retention. Data points represent group means
± SEM. *p<0.01 vs. sham and NIM811; #p<0.01 vs. sham, @p<0.05 vs. sham.
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3.3.3 NIM811 attenuates post-traumatic mitochondrial dysfunction and oxidative damage
The ability of NIM811 to inhibit mPTP in isolated mitochondria from naïve
animals was assessed using a calcium infusion assay. In vitro treatment of naïve
mitochondria with NIM811 indicated that NIM811 increases the Ca2+ buffering capacity
of isolated mitochondria and delays the onset of mPTP compared to vehicle treatment
(Fig. 3.3A). In order to elucidate the effects of NIM811 administration on mitochondrial
bioenergetic function, mitochondria were isolated at 6 h post-injury from the ipsilateral
hemisphere of animals administered NIM811 (10 mg/kg) or vehicle at 15 min postinjury. Mitochondrial respiration was measured using a Clark-type oxygen electrode.
Respiratory control ratios (RCR) were used as a metric for overall mitochondrial
functionality. RCR values (state III/state IV) represent the extent of coupling between
proton transport and ATP production. As expected, vehicle-treated rats showed
significantly lower RCR values (3.06 ± 0.18) than NIM811-treated rats (5.65 ± 0.27) (p <
0.0001) following TBI (Fig. 3.3B).

57

Fig. 3.3. NIM811 is a potent inhibitor of mPTP and NIM811 treatment attenuates injuryinduced impairments in mitochondrial bioenergetics following TBI. (A) Representative
Ca2+ infusion traces from isolated naïve mitochondria in the presence and absence of
NIM811 (1 µM). In the presence of NIM811, mitochondria buffered more of the infused
Ca2+ than in the absence of NIM811. Animals were subjected to a severe CCI TBI and
administered the optimal dose of NIM811 (10 mg/kg) or vehicle at 15 min post-injury.
(B) At 6 h post-injury, NIM811-treated rats demonstrated significantly higher RCRs than
vehicle-treated rats, indicating that coupling of the electron transport system to oxidative
phosphorylation was maintained. Bars are group means ± SEM. @p<0.0001 vs. vehicle.
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Mitochondrial oxidative stress and deficits in mitochondrial functioning have
been shown to occur simultaneously following experimental TBI (Opii, et al., 2007,
Singh, et al., 2006). In order to determine the effects of NIM811 treatment on
mitochondrial oxidative damage, a portion of the mitochondria isolated from the
ipsilateral cortex were used for quantitative measurement of 4-HNE, as an index of lipid
peroxidation, and protein carbonyls, as an index of protein oxidation, using slot blots and
OxyBlots, respectively. Analysis of oxidative damage markers at 6 h post-injury
demonstrated that mitochondria isolated from NIM811-treated rats had significantly
lower levels of 4-HNE (p < 0.01) and protein carbonyls (p < 0.02) (Fig. 3.4). These data
indicate that treatment with NIM811 attenuates TBI-induced mitochondrial oxidative
damage.
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Figure 3.4. Administration of NIM811 (10 mg/kg) reduces mitochondrial oxidative
damage following TBI. NIM811 administration significantly decreased levels of
mitochondrial (A) lipid peroxidation and (B) protein carbonyls at 6 h post-injury. Bars
are group means ± SEM. #p<0.05 vs. vehicle.
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3.4 Discussion
Following TBI, mitochondrial dysfunction precedes secondary cell death
(Robertson 2004). The overall hypothesis for the current study was that attenuation of
this dysfunction with NIM811 would result in neuroprotection. In the present study,
NIM811, which inhibits mPTP without affecting calcineurin, significantly increased
tissue sparing when compared to vehicle-treated animals. The dose-response of NIM811
is an inverted U-shaped curve, with 10 mg/kg as the most effective dose. The 10-mg/kg
dose of NIM811 was selected as the optimal dose based on these results and is in line
with a previous report of Mbye and colleagues (Mbye et al. 2008).
Human TBI results in significant memory dysfunction and potential TBI
therapeutics should be aimed at attenuating this common clinical observation. The
neuroprotective efficacy of NIM811 has been recently demonstrated following severe
TBI. However, prior to the current study the neuroprotective effects of NIM811 had yet
to be translated into improved cognitive endpoints. In the present study we determined if
the neuroprotective effects of NIM811 would translate into significant improvements in
MWM performance. Indeed the neuroprotection provided by the 10-mg/kg dose of
NIM811 translated into a significant reduction in brain injury-induced spatial learning
deficits in the acquisition phase and memory phase of the MWM. While there was a
general trend of NIM811 improving memory on every day of training, only on day 13 did
NIM811 treatment significantly decrease escape latency compared to vehicle treatment.
Also, on day 14 of training vehicle treated rats had significantly increased escape
latencies compared to sham animals (on day 14 NIM811 treated animals were not
significantly different than sham). During the probe trial on average approximately 3 out
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4 NIM811 treated animal crossed the platform at least once, whereas only 1 in 4 vehicle
treated animals crossed the platform.
Since mitochondrial dysfunction occurs as early as 15-30 min post-injury, it has
been suggested that therapeutic interventions targeting mitochondria must be initiated
early after TBI (Gilmer et al. 2009; Singh et al. 2006; Sullivan et al. 1998). In previous
studies, mice showed a significant improvement in mitochondrial function following a
single IP injection of NIM811 administered 15 min post-injury. Based on these findings,
it was determined that a single injection at 15 min post-injury may be sufficient to
attenuate the rapid mitochondrial dysfunction occurring following TBI. Based on our
dose-response studies, we decided to investigate the effects of treatment with the 10mg/kg dose of NIM811 on mitochondrial respiration compared to vehicle. We chose to
evaluate the effect of NIM811 or vehicle at 6 h post-injury based on previous studies
showing that mitochondrial dysfunction peaks between 6 and 12 h post-injury (Singh et
al. 2006; Xiong et al. 2007). Results from our mitochondrial studies indicated that 10
mg/kg of NIM811 was effective in attenuating trauma-induced mitochondrial dysfunction
compared to vehicle treatment. This improvement in mitochondrial function most likely
represents maintained mitochondrial electron transport as a result of NIM811-mediated
inhibition of mPTP formation (Sullivan et al. 1999).
Although the mechanisms of secondary injury are not completely understood,
increased free radical generation post-TBI and subsequent lipid peroxidation and protein
nitration appear to play a role in the progressive neuropathology associated with TBI
(Deng-Bryant et al. 2008; Deng et al. 2007; McCall et al. 1987; Readnower et al. 2010;
Singh et al. 2006). mPTP formation and mitochondrial oxidative damage occur
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simultaneously following TBI (Sullivan et al. 2005). Here, we demonstrate that a 10mg/kg dose of NIM811 significantly reduced levels of protein oxidation and lipid
peroxidation in rats following TBI. These findings are in line with the results observed in
mice by Mbye and colleagues (Mbye et al. 2008). Because NIM811 and CsA lack the
chemical structure to act as direct antioxidants or free radical scavengers, the reduction in
oxidative damage is most likely an indirect effect of maintained mitochondrial
homeostasis, which would result in fewer free radicals and less oxidative damage (Mbye,
et al., 2008).
It is well established that Ca2+ increases mitochondrial ROS production; however,
the mechanism through which Ca2+ induces ROS formation is largely unknown (Komary
et al. 2010; Votyakova and Reynolds 2005). Since mPTP decreases mitochondrial Ca2+
levels, it may be hypothesized that inhibition of mPTP would increase mitochondrial
ROS production. But, here, we show that mPTP inhibition actually decreases
mitochondrial oxidative stress. This finding may be explained by two possible
mechanisms: (i) mPTP formation results in inner membrane structural alterations leading
to increased ROS production or (ii) mPTP results in decreased clearance of ROS due to
impairment of antioxidant systems (Crompton 1999; Kowaltowski et al. 1995). In
isolated mitochondria, mPTP formation increases mitochondrial ROS production, and
inhibition of mPTP with CsA decreases ROS production (Maciel et al. 2001). These
findings suggest that the mechanism by which mitochondrial Ca2+ uptake promotes ROS
production is actually mediated through mPTP formation. This notion is supported by
the findings that Ca2+ does not increase ROS production without mPTP formation
(Hansson et al. 2008).
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The clinical utility of Cyp-D inhibitors, such as NIM811 and CsA, may be limited
by the overall role mPTP plays in both apoptosis and necrosis. In studies involving CypD knockout mice, Ca2+ and oxidative stress insults required mPTP for induction of cell
death while Bcl-2 mediated cell death did not require mPTP (Baines et al. 2005). Taken
together this may indicate that mPTP inhibition itself may not overcome all cell death
pathways initiated by the mitochondria.
To date, the efficacy of NIM811 has been demonstrated in multiple models of
neurodegeneration, including transient focal cerebral ischemia, spinal cord injury, and
TBI (Korde et al. 2007; Mbye et al. 2009; Mbye et al. 2008; McEwen et al. 2007;
Ravikumar et al. 2007). Despite the proven efficacy of CsA, NIM811 may have better
potential as a TBI therapeutic due to its reduced toxicity and specificity as a mPTP
inhibitor relative to CsA (Mazzeo et al. 2009). The substitution of isoleucine for leucine
at the fourth amino acid of CsA allows NIM811 to bind CyP-D and cyclophilin A (CyPA) but prevents NIM811 from inhibiting calcineurin. Like other cyclophilins, CyP-A
exhibits peptidylprolyl isomerase (PPIase) activity which is associated with chaperonelike actions which aid in de novo protein folding and protein repair/refolding following
stress (Andreeva et al. 1999). This PPIase activity may be especially important following
brain injury and may aid in recovery. One recent study demonstrated that Cyp-A protein
expression was increased following CCI TBI and that exogenous administration of CyPA following a stab wound decreased blood-brain barrier permeability and reduced tissue
damage (Redell et al. 2007). Our observed U-shaped dose-response could reflect this;
although inhibition of mPTP with 10 mg/kg of NIM811 was protective, perhaps the
higher doses became cytotoxic due to further inhibition of other cyclophilin family
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members, which indicates isoform-specific cyclophilin inhibitors may provide even
greater neuroprotection than either CsA or NIM811. Nevertheless, the current data
supports the involvement of the mPTP in TBI neuropathology and validates mPTP
inhibition as a potential neuroprotective target for TBI.
In summary, 10 mg/kg of NIM811 is the most effective dose for achieving
neuroprotection following TBI. NIM811 treatment is capable of improving mitochondrial
function and reducing mitochondrial oxidative stress when compared to vehicle treatment
following TBI. This is one of the first studies demonstrating that mPTP inhibition
following TBI can be directly translated into improved cognitive behavior. These data
highlight the importance of maintaining mitochondrial homeostasis following TBI. Since
NIM811 is less toxic than CsA, it may be administered at higher doses which may confer
a greater degree of neuroprotection following trauma.
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4. CHAPTER 4
Increase in Blood–Brain Barrier Permeability, Oxidative Stress, and Activated
Microglia in a Rat Model of Blast-Induced Traumatic Brain Injury
(Published in Journal of Neuroscience Research, 88, 3530-3539)
4.1 Introduction
Accumulating clinical evidence as well as experience in contemporary military
operations suggests that substantial short-term and long-term neurologic deficits can be
caused by blast exposure without a direct blow to the head (Cernak et al. 1999; DePalma
et al. 2005; Elder and Cristian 2009; Ling et al. 2009; Trudeau et al. 1998). With an
estimated 15% of troops serving in Iraq sustaining some level of neurological impairment
due to blast exposure, TBI has become the signature injury of this war (Hoge et al. 2008).
Hoge and colleagues reported a high correlation between service members who reported
symptoms consistent with mild TBI and those who received exposure to blast. Although
sharing common clinical features with both, brain injury caused by blast (bTBI) is
clinically distinct from closed head and/or penetrating TBI (Ling et al., 2009). While the
exact biophysics underlying bTBI are not completely understood, interaction with a fast
moving, transient pressure wave is generally accepted as the primary cause of brain
injury that results from blast exposure (DePalma et al. 2005; Elsayed 1997; Taber et al.
2006). Experimental studies in rodents have demonstrated a correlation between memory
dysfunction and distribution of neuropathological damage in the brain after exposure to
blast overpressure (BOP) (Cernak et al. 2001a; Cernak et al. 2001b).
Previous studies have also demonstrated that rats exposed to low and moderate
intensity BOP (83 kPa or 112 kPa) had lowered food intake and exercise performance
(Bauman et al. 1997) with similar findings being reported in sheep (Mundie et al. 2000).
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Rats exposed to low intensity BOP (20 kPa) displayed significant performance deficits on
rotametric and grip-strength tests (Moochhala et al. 2004; Saljo et al. 2009b) whereas
animal studies using moderate levels of BOP (126 kPa) have shown Morris water maze
performance impairment, gliosis, and fiber degeneration (Long et al. 2009). Reactive
gliosis, neuronal swelling, and cytoplasmic vacuolation have also been observed in the
hippocampus of rats subjected to thoracic blast injury (Cernak et al. 2001b). Rhesus
monkeys exposed to high BOP (207 kPa, 276 kPa, or 345 kPa) demonstrated significant,
albeit transient, memory and performance deficits (Bogo et al., 1971).
TBI can result in brain microvasculature and blood-brain barrier (BBB)
breakdown leading to increased BBB permeability. Disruption of the BBB following TBI
results in brain edema, a primary event that affects both morbidity and mortality
following TBI (Unterberg et al. 2004). Edema increases intracerebral pressure (ICP), and
leads to secondary ischemic injuries by impairing cerebral perfusion and oxygenation
(Unterberg et al., 2004). Following TBI, various mediators are released which enhance
vasogenic and/or cytotoxic brain edema. These include glutamate, lactate, H+, K+, Ca2+,
nitric oxide, arachidonic acid and its metabolites, free oxygen radicals, histamine, and
kinins (Unterberg et al., 2004). BBB permeability to endogenous proteins, such as
immunoglobulins (IgG), is increased following experimental TBI (Sullivan et al. 2000b;
Tanno et al. 1992). An additional consequence of BBB disruption is the infiltration of
leukocytes into brain tissue, activation of microglia and inflammation (MorgantiKossmann et al. 2007). There is some indication of a widespread activation of microglia
1-14 days after exposure to blast, however, it remains unclear if this activation was a
direct result of blast wave or it was caused indirectly by an increase in permeability in
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blood-brain barrier and transfer of inflammatory mediators from circulation (Kaur et al.
1995). Oxidative stress has been shown to play a critical role in the secondary injury
process following TBI. In recent work, our colleagues demonstrated that following both
controlled cortical impact and weight drop models of TBI there is a rapid increase in the
lipid peroxidation marker, 4-hydroxynonenal (4-HNE), and protein nitration marker, 3nitrotyrosine (3-NT) (<30 min post injury), which returned to control levels 24 h postinjury (Deng et al. 2007; Hall et al. 2004).
PK11195, an isoquinoline derivative, is an antagonist of the translocator
protein (TPSO) (18 kDa) (Banati et al., 1997). TPSOs, previously referred to as the
peripheral benzodiazepine receptor (PBR), play an important role in steriodogenesis by
acting as cholesterol pores in the outer mitochondrial membrane (Scarf et al. 2009).
TPSOs are absent from neurons but are expressed in high density in glial and ependymal
cells (Chen and Guilarte 2008). Increased PK11195 binding has been localized to
activated microglia in several animal models of CNS injury including TBI, ischemia, and
excitotoxic lesion models (Dubois et al. 1988; Gotti et al. 1990; Grossman et al. 2003).
The use of TPSO autoradiographic analysis as a marker of inflammation is advantageous
over other methods due to the high sensitivity and anatomical resolution of the technique
(Benavides et al. 2001).
To begin to elucidate the mechanism(s) involved in bTBI neuropathology the
current study was designed to assess acute changes in neurological function and to
characterize acute changes in BBB permeability and oxidative damage, and the subacute
inflammatory response of the brain following BOP exposure. The results demonstrate the
novel findings that following exposure to a moderate BOP (120 kPa) there is significant
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reflex suppression, disruption of the BBB, oxidative stress, and widespread microglia
activation. Taken together, these data suggest that bTBI shares mechanisms of
pathobiology that are hallmarks of injury in other models of TBI, which may widen
future avenues of neuroprotective interventions for blast injuries.
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4.2 Methods
4.2.1 Animals and exposure to blast
Adult virus-free male Sprague-Dawley rats (250 - 300 g; n = 49) were randomly
divided into blast-exposed (n = 44) and control group (n = 14). Animals were
anesthetized with isoflurane and positioned in a holder that prevented secondary and
tertiary blast injuries as previously described (Chavko et al. 2006). Animals were then
placed into the end of the expansion chamber of an air-driven shock tube (2.5 ft
compression chamber connected to a 15 ft expansion chamber) with their right side
ipsilateral to the direction of the BOP. Animals assigned to exposures were subjected to a
peak overpressure of 120 kPa. Control animals received anesthesia and were treated in
the same way except for the exposure to BOP.

4.2.2 Acute Neurological Assessment
Acute neurological function was assessed using a battery of tests that are
analogous to motor components of the Glasgow Coma Scale (GCS) as previously
described (Dixon et al. 1987). These tests measure the duration of suppression of a
response due to injury. Immediately following BOP exposure or control treatment, the
duration of suppression of three reflexes were acutely evaluated. The reflexes of control
animals were evaluated in order to determine the effects of anesthesia on reflex
suppression. The corneal reflex was assessed by lightly touching the eye to elicit a
blinking response. The paw flexion reflex was assessed by briefly applying a pinch
(approximately 0.2 kg/mm2) to the hind paw to elicit a withdrawal response. The righting
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response was tested by placing the animal on its back and timing the return to a
spontaneous upright position. Evaluation continued until all reflexes had returned.

4.2.3 Immunohistochemistry
For IgG immunohistochemical assessment a total of 24 animals were exposed to
blast and allowed to recover for either 0.5, 3, 24, or 72 hours following BOP exposure
(n=6/group). A total of 6 control animals were handled in a similar manner and did not
receive any BOP exposure. At the designated survival intervals animals were
anesthetized with pentobarbital (95 mg/kg body weight) and transcardially perfused with
phosphate buffered saline (PBS) followed by 4 % paraformaldehyde, pH 7.4. After
removal, the brains were placed in 4 % paraformaldehyde-sucrose (15%) for an
additional 24 hrs. Coronal sections (50 μm) were then cut using a freezing microtome
throughout the rostral caudal extent of the brain, extending through the septal area to the
most posterior extent of the hippocampus. BBB permeability was assayed on every
twelfth section from each animal with biotinylated anti-rat IgG antibody as previously
described (Hoane et al. 2006). Sections were rinsed with PBS and incubated in 0.3%
H2O2 in order to block endogenous peroxidase activity. Next sections were blocked in
10% normal goat serum with 0.2% Triton X-100 in PBS for 1 h at room temperature
followed by incubation in primary antibody overnight at 4⁰C (1:1000; biotinylated goat
anti-rat IgG, Vector Labs, Burlingame, CA). Sections were rinsed and incubated in
avidin-horseradish peroxidase complex (Vectastain ABC, Burlingame, CA) for 1 hour.
IgG

immunoreactivity

was

visualized

by

incubation

of

sections

in

0.05%

diaminobenzidine, 0.01% H202, and 0.3% imidazole for 10 minutes. Lastly, sections were
71

rinsed with PBS, mounted on gelatinized slides, and coverslipped with permount. IgG
immunoreactivity was quantified using a gray-level-index (GLI) as previously described
(Bisler et al. 2002). Quantification was performed using Image-Pro Plus software
(Mediacybernetics, Bethesda, MD) such that GLI values corresponded to the area of
immunoreactivity in relation to an area of interest. The GLI value for each section (~12
sections per animal) were calculated and averaged in order to determine the percent total
brain area immunoreactive for IgG. These values were then averaged for each group.
For immunohistochemical detection of brain oxidative stress levels a total of 6
animals were subjected to BOP and allowed to recover for either 3 h or 24 h following
BOP exposure. A total of 3 control animals were handled in a similar manner and did not
receive any BOP exposure. At the designated survival intervals animals were
anesthetized with pentobarbital and perfused with PBS and 4 % paraformaldehyde.
Brains were placed in 4 % paraformaldehyde-sucrose (15%) for an additional 24 hrs.
Coronal sections (50 μm) were then cut using a freezing microtome throughout the rostral
caudal extent of the brain, extending through the septal area to the most posterior extent
of the hippocampus. Free floating sections were double-labeled for 3-NT (1:1000; mouse
anti-3NT monoclonal antibody, Upstate, Lake Placid, NY) and 4-HNE (1:5000; rabbit
anti-HNE polyclonal antibody, Calbiochem, San Diego, CA) and visualized by infrared
immunohistochemistry as previously described with few modifications (Hawes et. al.,
2005). Briefly, sections were washed three times for 5 min each in PBS, followed by
adduct reduction in 0.1 M NaBH4 in 0.1 MOPS (Sigma) for 10 min. Following reduction
sections were rinsed three times for 5 min each in PBS, followed by blocking in 10%
normal goat serum with 0.2% Triton X-100 in PBS for 1 hour at room temperature.
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Sections were incubated in primary antibodies overnight at 4⁰C. Before incubation in
secondary antibody, sections were washed three times for 5 min each in PBS. Sections
were then incubated with secondary antibodies for 2 h at room temperature (1:20,000;
IRDye700DX conjugated anti-mouse IgG; Gilbertsville, PA) (1:10,000; IRDye800
conjugated anti-rabbit IgG; Gilbertsville, PA). All sections were rinsed three times for 5
min each in PBS and mounted onto Fisher Superfrost Plus Slides. Slides were scanned
simultaneously on a LICOR Odyssey Infrared Imager (LI-COR Biosciences). The
fluorescence intensity for each section (~12 sections per animal) was quantified using an
area of similar size throughout each section. In order to obtain a value for each animal the
levels of 3-NT and 4-HNE for each section were averaged. These values were then
averaged for each group.
For assessment of microglia morphology antibodies against CD11b/c that
recognize microglia-specific complement type 3 receptor were utilized. Briefly,
endogenous peroxidase activity was blocked using 0.3% H2O2. Next sections were
blocked in 10% normal goat serum with 0.2% Triton X-100 in PBS for 1 h at room
temperature followed by incubation in primary antibody overnight at 4⁰C (1:1000; mouse
anti-rat CD11b/c; BD Pharmigen, San Diego, CA). Sections were then incubated in
secondary antibody for 2 h at room temperature (1:500; biotinylated goat anti-mouse;
Vector Laboratories, Burlingame, CA). Sections were rinsed and incubated in avidinhorseradish peroxidase complex (Vectastain ABC, Burlingame, CA) for 1 hour. IgG
immunoreactivity was visualized by incubation of sections in 0.05% diaminobenzidine,
0.01% H202, and 0.3% imidazole for 10 minutes. Lastly, sections were rinsed with PBS,
mounted on gelatinized slides, and coverslipped with permount.
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4.2.4 [3H]PK11195 Autoradiography
For autoradiography studies a total of 14 animals were subjected to BOP and
allowed to recover for either 5 or 10 days following exposure (n=7/group). A total of 5
control animals were given the same treatment except for BOP exposure. Animals were
euthanized and their brains were immediately removed and frozen in isopentane on dry
ice. Brains were sectioned (16 µm) on a cryostat and mounted on Fisher Superfrost Plus
Slides. TPSO autoradiography was performed using 1 nM [3H]PK11195 ligand
(PerkinElmer, Boston, MA, specific activity=85.5Ci/mmol) as previously described
(Kelso et al., 2009). Brain sections were preincubated in 50 mM Tris- HCl, pH 7.4 at 4⁰C
for 15 minutes, followed by incubation with radioactive ligand at 4⁰C for 2 hours. The
binding was terminated by washing sections in 50 mM Tris- HCl, pH 7.4 (3 x 3 min),
followed by dipping in ice cold water. The sections were exposed to Kodax BioMax
Autoradiography Film (Kodak, Rochester, NY) for 55 days. All films were developed
using a Kodak D-19 developer and analyzed using NIH image v1.59 on a Power
Macintosh connected to a Sony XC-77 CCD camera via a Scion LG-3 frame-grabber
(Scion, Inc., Frederick, MD). Autoradiograph data was quantified by densitometry.

4.2.5 Statistics
Individual reflexes (corneal, paw flexion, and righting) were analyzed by onetailed t-test. Data from immunohistochemical assays were analyzed by one-way ANOVA
followed

by

Student

Newman-Keuls

(SNK)

post-hoc

analysis.

[3H]PK11195

autoradiography results were analyzed by two-way repeated measures (hemisphere)
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ANOVA followed by Bonferroni post-hoc analysis. Significance was accepted as p<0.05.
All values are presented as means ± SEM.
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4.3 Results
4.3.1 Effect of blast overpressure on acute neurological function and brain morphology
Recently Hamm (2001) demonstrated that reflex suppression is a sensitive predictor of
injury effect, therefore acute neurological deficits as a result of BOP exposure were
assessed using a battery of reflexes which test somatomotor function (Hamm 2001). The
survival rate of animals following BOP exposure was 98%. The return of the corneal
reflex in BOP exposed animals (23.6 ± 2.2 sec) was significantly delayed compared to
control animals (14.33 ± 6.6 sec) (p<0.05). Additionally, BOP exposure resulted in a
significant suppression of the paw flexion reflex (47.7 ± 4.0 sec) compared to control
animals (21.8 ± 4.5 sec) (p<0.01) (Fig. 4.1). However, no significant differences were
measured between the righting reflexes of either group. There was no evidence of tissue
disruption or tissue loss in BOP exposed animals (Fig. 4.2).
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Figure 4.1. Effect of BOP on acute neurological functioning immediately following
exposure. Exposure to blast (full columns) significantly delayed the return of corneal and
paw flexion reflexes compared to control (open columns). The data represents the mean
duration of suppression ± SEM. Significance (t-test) is denoted as follows: #p<0.05,
*p<0.01 vs. control.
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Figure 4.2. Representative images of H & E stained brain sections of control (A) and at
3 days post blast 120 kPa (B). There were no overt signs of tissue disruption or cell loss.
Scale bar denotes 1 mm.
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4.3.2 Effect of blast overpressure on IgG immunoreactivity
The spatial extravasation of endogenous IgG immunoreactivity was used as an index for
BBB breakdown following BOP exposure. BBB disruption is a well-established hallmark
following brain injury and has been assessed in several models of TBI. Qualitative
assessment of IgG extravasation revealed that at 3 and 24 h following BOP exposure
there was a conspicuous increase in IgG immunoreactivity in the outer most layer of the
cortex. An ANOVA revealed a significant group difference (F[4,22]= 12.77, p<0.0001)
in IgG immunoreactivity following BOP exposure. Following BOP exposure, post-hoc
comparisons revealed a significant increase in IgG immunoreactivity at 3 (p<0.001) and
24 h (p<0.01) post BOP exposure (Fig. 4.3 & 4.4). Although not significant there was a
trend towards increased IgG immunoreactivity at 0.5 h post injury surrounding the lateral
ventricles.
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Figure 4.3. Effect of 120 kPa BOP on brain IgG immunoreactivity. The images are
representative for A - Control animals; B - 0.5 h post blast; C - 3 h post blast; D - 24 h
post blast; E - 3 days post blast. Increased IgG immunoreactivity in layer I of the cortex
was observed at 3 and 24 h following exposure. Although not significant there was
increased staining in the area surrounding the lateral ventricles (4 out of 6 brains) at 0.5 h
post blast. There was no difference in IgG staining in brains 3 days post exposure
compared with controls. Scale bar denotes 1 mm.
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Figure 4.4. Quantification of IgG immunoreactivity in brain sections after exposure to
blast. Significant increases in IgG staining were observed at 3 and 24 h after exposure
compared to control. The data represents the percentage of brain area stained for IgG ±
SEM. Significance with ANOVA followed by post hoc analysis (SNK) as follows:
*p<0.01 vs. control; #p<0.05 vs. 72 hr.
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4.3.3 Effect of blast overpressure on oxidative stress
Oxidative stress is known to play a role in the secondary injury cascade following TBI; in
the present study we determined 3-NT and 4-HNE levels following BOP exposure using
quantitative immunohistochemistry. An ANOVA revealed a significant group difference
(F[2,6]= 11.24, p<0.01) in 4-HNE levels following BOP exposure at 3 h post-exposure
(p<0.01). 4-HNE levels returned to control values at 24 h post-exposure. Similarly, there
was a significant group difference (F[2,6]= 11.55, p<0.01) in 3-NT levels at 3 h
following exposure (p<0.05) which returned to control values at 24 h post-exposure (Fig.
4.5).
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Figure 4.5. Quantification of 4HNE (A) and 3NT (B) levels in brain sections after
exposure to blast. Significant increases in 3NT and 4HNE levels were observed at 3 h
after exposure compared to control. At 24 h after exposure, 3 NT and 4HNE levels
returned to control values. The data represents the mean fluorescence ± SEM.
Significance with ANOVA followed by post hoc analysis (SNK) as follows: *p<0.05.
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4.3.4 Effect of blast overpressure on TPSO binding and microglia morphology
Inflammation has been demonstrated in multiple models of TBI; in the present study
microglial activation was determined using TPSO autoradiographic localization. The
effects of blast exposure on TPSO density were evaluated using [3H]PK11195
autoradiography in several brain regions at 5 and 10 days post blast (Fig. 4.6). A two-way
ANOVA was significant for effect of BOP exposure (F[2, 16] = 2.287, p<0.001), but not
for hemisphere (F[1, 16] = 11.20, p>0.05) (Table 4.1). No significant interaction between
BOP exposure and hemisphere existed (F[2, 16] = 1.494, p>0.05). At 5 days post blast,
post-hoc testing revealed a significant increase in the density of [3H]PK11195 binding in
the ipsilateral dentate gyrus (p<0.001) and contralateral dentate gyrus (p<0.05). At 10
days post blast, post-hoc comparisons revealed a significant increase in [3H]PK11195
binding in the contralateral dentate gyrus (p<0.001), ipsilateral dentate gyrus (p<0.001),
contralateral substantia nigra (p<0.01), and contralateral ventral hippocampus (p<0.05).
In order to further demonstrate the response of microglia to BOP exposure
antibodies against CD11b/c were used to visualize microglia morphology. In the cortex,
hippocampus, and substantia nigra of control animals microglia demonstrated a resting
morphology characterized by highly ramified processes (Fig. 4.7). In contrast microglia
in the hippocampus from animals exposed to blast displayed an activated morphology
characterized by clustering. In addition to this microglia in the substantia nigra of BOP
exposed animals revealed activated morphology characterized by rounded cell bodies and
fewer ramifications.

84

Figure 4.6. Effect of exposure to 120 kPa BOP on TPSO expression. Pseudocolored
autoradiogram of brain sections labeled with [3H]PK11195 in control and in 5 or 10 days
post exposure animals. Four different levels are shown: A - anterior striatum; B - dorsal
hippocampus; C - dorsolateral thalamus; D - ventral hippocampus. Brain regions
abreviated as follows: primary motor cortex (M1), striatum (St), dentate gyrus (DG),
dorsolateral thalamus (DT), ventral hippocampus (VH), and substantia nigra (SN).
Prominent areas of high TPSO density in control animals are restricted to
ventricular/choroid plexus regions. High density areas of TPSO in exposed animals are
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the dentate gyrus and substantia nigra. The scale shown at bottom shows the range from
low to high expression.
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Table 4.1. Quantification of TPSO expression in selected brain regions. There was a significant increase in PK11195 binding
in the dentate gyrus at both survival intervals. In addition the TPSO expression was increased in both the contralateral
substantia nigra and ventral hippocampus 10 days after blast. The data represents the mean density of [3H]PK11195 binding
(arbitrary optical units) ± SEM. Significance from control is denoted as follows: *p<0.001; **p<0.05.
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Figure 4.7. Effect of 120 kPa BOP on microglia morphology in selected brain loci. In
order to confirm PK11195 autoradiographic data demonstrating microglial activation in
the dentate gyrus and substantia nigra, antibodies against CD11b/c were employed to
visualize microglial morphology. In sham animals all regions that were evaluated
contained microglia with resting morphology characterized by highly ramified processes
(A-C). In the cortex of animals exposed to blast microglia also displayed resting
morphology (D). Exposure to blast resulted in activated microglial morphology
characterized by microglial clustering in the hippocampus (dentate gyrus, E). In addition
activated microglia morphology in the substantia nigra is revealed by microglia with
rounded cell bodies and reduced ramifications (F). Scale bar = 50 µm.
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4.4 Discussion
Brain injury in rats as a result of exposure to BOP using an air-driven shock tube
was used to study the progression of neuropathological processes that could be relevant
to blast exposed populations. The systemic effects of the level of blast (~120 kPa) used in
the present study were previously characterized and it was shown to induce moderate
pulmonary damage with an acute inflammatory responses that were resolved by 8 days
(Chavko et al., 2006). The exposure to this level of BOP does not produce lethal damage
and the survival rate of rats at 120 kPa under isoflurane anesthesia is more than 90%. In
the present study we looked for some basic neurological and neuropathological changes
in the brain and demonstrated that 120 kPa BOP exposure produced acute reflex
suppression in rats which was similar to suppression observed in other models of diffuse
brain injury (Denny-Brown and Russell 1940; Dixon et al. 1987; Fijalkowski et al. 2007).
This extent of reflex suppression is consistent with concussion and mild TBI which
closely resembles the clinical manifestation of bTBI (Bruns and Jagoda 2009; Jones et al.
2007). Previous studies have demonstrated a dose response relationship between the
extent of acute neurological impairment and overall cognitive outcome following
experimental diffuse brain injury (Beaumont et al. 1999). Long and colleagues (2009)
reported that following 126 kPa BOP exposure there is transient cognitive dysfunction;
the observed reflex suppression in the present study predicts these findings by Long. The
results also demonstrate increased IgG immunoreactivity in the brain 3 and 24 h after
exposure indicating increased early permeability of BBB followed by microglia
activation at 5 and10 days post-exposures.
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BBB breakdown has been shown to occur early after TBI; it is mostly transient
and the time course of the BBB opening varies in different models. In a fluid percussion
model of injury, BBB damage in the rat brain was most pronounced within the first hour
after TBI and was reestablished by 6 h after injury (Tanno et al. 1992). Others also
reported that the BBB sealed within a few hours after fluid-percussion injury (Enters et
al. 1992). We observed significant BBB breakdown following blast which was limited to
layer I of the cortex and was considerably smaller in comparison to diffuse fluid
percussion brain injury, where overt BBB breakdown was observed throughout the
neocortex, hippocampus, and thalamus (Kelley et al. 2007). Similarly to other TBI
models BBB disruption was transient and appeared recovered by 3 days.
It is generally thought that the BBB opening is a major factor contributing to the
presence of brain edema observed in TBI. However, in some TBI models, edema
formation clearly does not correspond with BBB opening (Beaumont et al. 2000).
Instead, cytotoxic mechanism is thought as the major mechanism of edema formation in
TBI. Despite this a permeable BBB can provide a route for passive fluid movement and
thus worsening the cytotoxic cell edema.

Recently, Saljo et al (2009) reported a blast

dose-dependent rise in ICP in rats exposed repetitively 3 times to blast, and an increasing
time delay in elevation with decreasing intensity of exposure. While the initial elevation
took place within 30 min after exposure to 60 kPa, it did not appear until after 2 h and 6 h
after exposure at 30 and 10 kPa, respectively. The delayed BBB opening and similar time
course in ICP increase may indicate a contribution of vasogenic component to brain
damage after exposure to blast.
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BBB breakdown in TBI can be a result from the initial insult or the product of
secondary injuries, such as accumulation of inflammatory cytokines. Whalen et al.
(1997) found a pattern of transient BBB opening that was independent of inflammation;
the BBB was leaky within the first 30 minutes to 4 hours after controlled cortical impact
in rats whereas white blood cell accumulation peaked at 24 hours (Whalen et al. 2000). It
was concluded that BBB damage was not related to the white blood cell accumulation
and inflammation. It was previously shown that exposure to BOP produced early (1-3 h
post exposure) recruitment of polymorphonuclear leukocytes (PMNs) in peripheral blood
at the level of blast in the present study (Gorbunov et al. 2004). Therefore, contribution of
inflammation to the BBB opening cannot be ruled out and needs further investigation.
In virtually all pathological conditions of the CNS, accumulation and activation of
microglia precedes or is concomitant to neuronal and glial cell damage. Microglia as the
principal immune cells in the CNS are known as a source of highly cytotoxic substances
including proinflammatory cytokines, reactive oxygen intermediates, proteinases, and
complement proteins (Giulian et al. 1995; McGeer et al. 1993; Rieske et al. 1989).
Microglia derived oxygen free radicals as well as subsequent reaction products, hydrogen
peroxide and peroxynitrite, have the potential to harm cells and have been implicated in
contributing to oxidative damage and neurodegeneration in neurological diseases. Our
findings show the inflammatory response in the brain long after initial impact and with
the absence of detectable cell loss. It has been suggested that microglial activation in TBI
cannot be exclusively attributable to the infiltration of blood-borne macrophages or
molecules from the circulating blood. This implies that the microglial activation
occurring is caused largely by intrinsic mechanisms within brain tissue, e.g .as a response
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to diffuse axonal injury. Several recent reviews have suggested that inflammation may
serve as a biomarker for bTBI (Agoston et al. 2009; Svetlov et al. 2009). Following a
single severe blast, Kaur and colleagues previously demonstrated that there is widespread
microglial activation up to 14 days post blast (Kaur et al. 1995). In addition,
ultrastructural findings by Cernak and colleagues demonstrated glial reaction in the
hippocampus of rats exposed to high levels of BOP (Cernak et al. 2001b). Recently Long
and colleagues reported that following moderate levels of BOP (126 kPa) there was
widespread gliosis throughout all levels of the brain (Long et al. 2009). However it was
unclear whether microglia and/or astrocytes were activated and the regional pattern of
inflammation remained uncertain.
It was recently shown that increased PK11195 binding in some brain areas
corresponds with microglial activation following TBI (Benavides et al. 2001;
Raghavendra Rao et al. 2000). In order to provide higher anatomical resolution of
regional microglial activation following a moderate level of BOP we selected PK11195
binding as a surrogate marker of microglial activation. We demonstrated increased
PK11195 binding in the dentate gyrus, substantia nigra, and ventral hippocampus 5 days
and 10 days after exposure to blast. At 10 days the inflammatory response appeared to be
evolving further as increased binding was observed compared to 5 days. While at 5 days
after exposure the distribution of lesions was localized bilaterally in both hemispheres,
latter at 10 days increased binding density increase was distributed more contralaterally
to the site of impact. This distribution of microglia has some analogy with previously
published data on the vasospasm distribution after exposure to blast. Unlike conventional
TBI, traumatic cerebral vasospasm (TCV) often occurred in vessels far distal to the area
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of fragment penetration in the hemisphere contralateral to the injury. It was suggested
that, in addition to the fragment injury, propagation of the blast wave through the tissue
could have caused TCV (Armonda et al. 2006). Another possibility is migration of toxic
components of microglia activation products from the site of injury into distant regions
(Gong et al. 2000).
The results presented clearly illustrate the selective vulnerability of the
hippocampus and substantia nigra to BOP exposure. The high density of NMDA
receptors present in the hippocampus may be partially responsible for the vulnerability of
the hippocampus to excitotoxic insults (Butler et al. 2009). It was shown by positron
electron tomography (PET) that PK11195 can visualize excitotoxic lesions in the living
human brain (Groom et al. 1995). High vulnerability to oxidative stress of dopaminergic
neurons in the substantia nigra and resultant mitochondrial dysfunction may contribute to
the observed increase in microglia activation in substantia nigra (Hastings 2009).
Cernak and colleagues demonstrated that high levels of BOP result in an increase
in brain nitric oxide production and lipid peroxidation as early as 3 h post-exposure that
resolves by 5 days post-exposure. However, prior to the current study, oxidative stress
following a moderate level of blast remained undetermined. Here we report that as early
as 3 h post-exposure there is a significant increase in 3-NT and 4-HNE levels. At 24 h, 4HNE and 3-NT levels had returned to control values. This indicates that there is a rapid
increase in oxidative stress following moderate BOP exposure and that oxidative stress is
at least partially occurring concomitantly with BBB breakdown. It has been postulated
that vascular abnormalities following TBI are dependent on the production of oxygen
radicals (Kontos and Povlishock 1986; Pun et al. 2009). Therefore antioxidants may
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represent one potential neuroprotective target for therapeutic intervention following
bTBI, which may in turn reduce other downstream pathological processes (i.e. BBB
breakdown).
In summary, our data demonstrate that bTBI likely share some common
mechanisms of injury with other TBI models. In this study we demonstrated that
inflammation likely plays a role in the neuropathology associated with bTBI. We report
significant BBB breakdown that resolved by 3 days post exposure. Oxidative damage
markers increased rapidly and resolved by 24 h post exposure. Taken together our results
clearly show that the brain is susceptible to BOP exposure and that specific brain regions
are more susceptible to blast than others.
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5. CHAPTER 5
Discussion and Conclusions
5.1 Review
The wars in Iraq and Afghanistan have resulted in a high prevalence of TBI in
military populations. Estimates of incidence of blast TBI range from 15-60 % of all
deployed US military combatants (Ling et al. 2009). Since traumatic brain injury is often
an “invisible wound”, its diagnosis can be extremely difficult, especially in the context of
explosive blast injury. Currently, there is a great deal of investigation involving the
mechanism(s) by which blast causes brain injury. In addition to the military contribution,
mild TBI (concussion) in the US is gaining popular attention in the context of athletic
injuries. In fact, over 18 % of all TBIs in the US are attributable to athletic injuries
(Meehan and Bachur 2009). While concussion results in symptoms that usually resolve
over the first few weeks following injury, some symptoms may persist for months to
years.
The pathology associated with TBI occurs biphasically, with initial (primary)
mechanical damage followed by a delayed secondary injury cascade. The secondary
injury process is complex and involves multiple pathological events such as
excitotoxicity, oxidative damage, mitochondrial dysfunction, and inflammation.
Although the pathological processes following TBI are well defined an effective
therapeutic for TBI remains elusive.
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The results from the experiments in this dissertation have demonstrated that: (I)
Cyclophlin D plays a key role in TBI pathology and is a valid target for neuroprotective
intervention; (II) Administration of NIM811, a CypD inhibitor, is neuroprotective and
improves cognition following TBI; and (III) Blast exposure results in neuropathology
similar to other models of TBI.
5.2 Cyclophilin D’s involvement in TBI
Until now, CypD’s involvement in TBI pathology was entirely based on indirect
evidence. This evidence was based on the assumption that the neuroprotective
mechanism of CsA was through inhibition of CypD. Here we have demonstrated that
genetic knockout of CypD increases tissue sparing and protects CA3 hippocampal
neurons following TBI. These data suggest that CypD is a valid therapeutic target for
TBI.
The selective protection of CA3 neurons observed in CypD knockout mice may
be explained by the relative vulnerability of individual hippocampal subfields following
insult. Selective vulnerability of CA1 neurons is well-documented following hypoxiaischemia insult (Kirino 1982; Kirino and Sano 1984). In fact, it has been shown that
inhibition of complex II with malonate results in a selective loss of CA1 neurons in rats
(Davolio and Greenamyre 1995). This may be especially relevant to these studies given
that we observed only partial mitochondrial protection and that complex II driven
respiration was significantly decreased in both wild-type and CypD knockout mice
following TBI. Therefore, CA3 neurons maybe intrinsically less susceptible to insult and
in turn maybe more amenable to therapy.
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Protection of CA3 neurons may have important implications for behavioral
function following TBI. The CA3 region has been shown to play a critical role in spatial
memory acquisition and in the formation of long-term spatial memory (Florian and
Roullet 2004). Since CypD knockout resulted in CA3 protection this suggests that
modulation of CypD may improve memory following TBI.
Next we choose to evaluate the efficacy of the CypD inhibitor, NIM811,
following TBI. NIM811 is a more specific mPTP inhibitor than CsA and therefore has
greater therapeutic potential. NIM811 resulted in significant neuroprotection which
translated into improved behavioral function. Although we did not directly assess the
effects of NIM811 treatment on hippocampal integrity, we speculate that the
improvement in memory acquisition in NIM811 treated animals is related to a selective
protection of CA3 neurons like we observed in our CypD knockout studies. Future
studies may address the effects of NIM811 treatment on hippocampal integrity following
TBI.
We also report that the protection produced by both genetic ablation of CypD and
pharmacological inhibition of CypD with NIM811 is likely mediated through
maintenance of mitochondrial function. An important phenomena associated with
glutamate excitotoxicity is delayed calcium dysregulation (DCD) which refers to the
delayed loss of Ca2+ homeostasis that leads to cell death (Starkov et al. 2004). Following
glutamate exposure, initially intracellular Ca2+ levels of cultured neurons rapidly increase
and fall (as a result of mitochondrial buffering of Ca2+), this is followed by a delayed
irreversible increase in intracellular Ca2+ (Manev et al. 1989). This secondary rise in Ca2+
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is thought to be mediated by an increase in mitochondrial ROS production (Castilho et al.
1999). Induction of mPTP, through an unknown mechanism, has been shown to result in
increased ROS production (Kowaltowski et al. 1998). This increase in ROS production is
thought to promote an increase in plasma membrane Ca2+ permeability (Wehage et al.
2002). Inhibition of mPTP, through CypD knockout or pharmacological inhibition, is
hypothesized to be the underlying mechanism of protection in the studies highlighted in
this dissertation. In fact, the NIM811 studies demonstrated that inhibition of CypD results
in decreased mitochondrial oxidative damage. Maintenance of mitochondrial homeostasis
through modulation of CypD likely decreased ROS production and prevented DCD and
subsequent cell death in these studies.
It is interesting that the observed dose-response curve for NIM811 and CsA are
both U-shaped and that the optimal dose of NIM811 (10 mg/kg) is less than the optimal
dose of CsA (20 mg/kg) (Sullivan et al. 2000b). Since the optimal dose of NIM811 is less
than CsA this may indicate that it is a more potent inhibitor of mPTP than CsA in vivo.
Although these studies provide evidence that CypD plays a role in TBI the
question related to the neuroprotective mechanism of CsA remains unanswered. In fact,
these studies in which wild-type mice and CypD knockout mice are being administered
CsA are ongoing in our laboratory. If knockout of CypD and administration of CsA
results in an additive affect it would indicate that CsA is providing protection at least
partially in a mechanism independent of CypD.
To date, CypD knockout has proven beneficial in multiple neurodegenerative
models including hypoxic-ischemic brain injury and Alzheimer’s disease (Du et al. 2008;
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Wang et al. 2009). Also, NIM811 has been shown to be neuroprotective in multiple CNS
injury models including TBI, spinal cord injury, and transient focal forebrain ischemia
(Korde et al. 2007; Mbye et al. 2008; McEwen et al. 2007). These studies, along with
those contained in this dissertation, demonstrate that CypD is critically involved in TBI
and that modulation of CypD following TBI has great therapeutic potential.
5.3 Blast TBI
Because of improvements in body armor soldiers are surviving greater explosions
and as such TBI has become a military epidemic. Also, the use of improvised explosive
devices (IEDs) in Iraq and Afghanistan has contributed to the increased prevalence of
TBI in the military. A renaissance in blast TBI research has occurred since the start of the
current conflicts and it is increasingly evident that the brain is susceptible to primary blast
forces. The development of relevant models of blast injury has shed new light on the
pathology of blast TBI.
The studies presented here have attempted to characterize the time-course for
well-established markers of TBI pathology in a clinically relevant blast TBI model. We
showed that blast overpressure results in an early transient impairment of neurological
function. The modest impairment likely indicates that our blast model is modeling a
concussion-like injury. In fact, soldiers exposed to blast often report symptoms (i.e.
confusion, amnesia, headache) consistent with concussion injury (Lippa et al. 2010). The
similarity between the neurological impairment in our model and the clinical
manifestation of blast are striking. In fact, studies by Long and colleagues have
demonstrated that our blast model results in cognitive dysfunction as determined by
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MWM performance (Long et al. 2009). These observations help validate the clinical
relevancy of our model.
Our results demonstrate that brain oxidative damage occurs rapidly (<3 h)
following TBI and resolves by 24 h post-injury. This increase in oxidative stress partially
occurred concomitantly with increases in BBB permeability. Oxidative stress is known to
promote BBB breakdown, which suggests a causal role for ROS in BBB dysfunction
(Pun et al. 2009). Thus, antioxidant therapy may be one potential therapeutic strategy for
blast TBI that could attenuate rises in ROS and in turn decrease alterations in BBB
permeability.
Increased PK11195 binding has been shown to correlate with activated microglia
following TBI (Woodcock 2009). As such we used PK11195 as a marker for activated
microglia and showed that there is increased neuroinflammation in both the hippocampus
and substantia nigra following blast. Since the hippocampus is intimately involved in
memory, damage to the hippocampus could explain cognitive dysfunction following
blast.
5.3.1 Blast commentary
In studies which only subjected the head to blast (i.e. abdomen and chest shielded
with a Kevlar vest) neuropathology was reduced compared to whole body blast
(Koliatsos et al. 2011; Long et al. 2009). These data indicate a systemic involvement in
brain injury following blast. One hypothesis is that forces from blast waves impacting the
thorax are transmitted via the large blood vessels to the brain, resulting in damage
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(Cernak and Noble-Haeusslein 2010). Also systemic injury could result in a production
of proinflammatory cytokines which could enter the brain following BBB breakdown and
promote inflammation. This may be true in our blast model since it has been shown to
result in moderate pulmonary damage (Chavko et al. 2006). Therefore in our studies we
cannot rule out a systemic (polytrauma) contribution to the observed brain injury in our
blast model.
Clinical and experimental data suggests that repetitive mild TBI may cause
cumulative damage to the brain (Weber 2007). Animal models have shown learning and
cognitive dysfunction following repeated mild TBI that was absent following a single
injury (DeFord et al. 2002) (Creeley et al. 2004). However the time lapse between the
first injury and second injury appears to be an important determinant of overall outcome,
if given enough time the brain may recover and the cumulative effect of the injuries may
diminish (Weber 2007). Occupationally military personnel have an increased risk of
repetitive BOP exposure and therefore may have a higher incidence of repetitive injury
(Elsayed and Gorbunov 2007). The hypothesis that damage caused by one mild BOP
exposure would have cumulative effects on the brain if BOP exposure is repeated needs
attention. One group found that following three repeated low level blasts there was a
dose-dependent increase in intracranial pressure (Saljo et al. 2009a). However, this study
did not include any histopathological evidence of a cumulative effect of blast. These
repeated blast studies would have important implications for return to work/combat
guidelines for soldiers.
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The rationale behind pretreatment seems especially pertinent to military
populations. Since the mechanisms of injury following TBI evolve rapidly, having a
compound “on-board” at the time of injury may produce the greatest protection. Creatine
is a commonly used dietary supplement that has neuroprotective efficacy and could be
taken prophylactically by warfighters (Dedeoglu et al. 2003; Rabchevsky et al. 2003;
Scheff and Dhillon 2004; Sullivan et al. 2000a). Creatine likely provides protection by
maintaining mitochondrial homeostasis through increasing levels of phosphocreatine and
maintaining mitochondrial structural integrity. Antioxidants, such as reveratrol, could be
administered prophylactically to those at greater risk of TBI. Reserveratrol has been
shown to be neuroprotective and improve cognition following TBI (Singleton et al.
2010).
In summary, blast TBI represents a major public health problem with social and
economic implications. Research initiatives elucidating the mechanisms of injury
following blast will lead to the development of therapeutic strategies and better
diagnostic tools.
5.4 Concluding Remarks
Based on the results highlighted in this dissertation, along with reports from
others, CypD plays a critical role in cell death following TBI and indicates that
pharmacological inhibition of CypD remains a plausible therapeutic strategy for TBI. We
chose to use NIM811 in our studies based on its specificity for CypD in relation to CsA.
Indeed NIM811 administration conferred neuroprotection following TBI. These results
warrant further studies evaluating the therapeutic window for NIM811. Also, NIM811
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efficacy needs to be determined in other models of TBI. Since our results indicate that
blast causes neuropathology in the rat brain, further investigation is needed to evaluate
neuroprotective compounds in blast TBI.
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APPENDIX A: list of acronyms and abbreviations

3-NT

-

3-nitrotyrosine

4-HNE

-

4-hydroxynonenal

AIF

-

Apoptosis inducing factor

AMPA

-

α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptors

ANT

-

Adenine nucleotide translocase

BBB

-

Blood brain barrier

BOP

-

Blast overpressure

bTBI

-

Blast traumatic brain injury

CCI

-

Controlled cortical impact

CsA

-

Cyclosporin A

cTBI

-

Civilian traumatic brain injury

CypD

-

Cyclophilin D

DCD

-

Delayed calcium dysregulation

ETC

-

Electron transport chain

GCS

-

Glasgow Coma Scale

mPTP

-

Mitochondrial Permeability transition pore

MWM

-

Morris Water Maze

NIM811

-

N-methyl-4-isoleucine-cyclosporin

NMDA

-

N-methyl-daspartate

PBR

-

Peripheral benzodiazepine receptor

ROS

-

Reactive oxygen species

TBI

-

Traumatic brain injury

TPSO

-

Translocator protein

VDAC

-

Voltage-dependent anion channel
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APPENDIX B: Effects of CypD on spatial memory

Morris Water Maze training data collapsed across all training days. CypD knockout
resulted in a genotype-specific decrease in MWM performance compared to wild-type.
Similar results were reported by Mouri and colleagues (Mouri et al. 2010). In these
studies, inhibition of CypD with CsA produced similar MWM deficits as CypD
knockout.
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APPENDIX C: Ca2+ buffering capacity of CypD knockout mitochondria and wild-type
mitochondria

Mitochondria isolated from naïve wild-type and CypD knockout animals were used to
assess the effect of in vitro NIM811 treatment (1 µM) on mitochondrial Ca2+ buffering
capacity and mPTP. CypD knockout mitochondria were capable of buffering
approximately 20 % more Ca2+ before undergoing mPTP than wild-type mitochondria.
CypD knockout and wild-type + NIM811 mitochondria demonstrated similar Ca2+
buffering capacity.
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